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Background: All countries have signed up to the United Nations (UN) Sustainable 
Development Goals (SDGs), including Target 3.8 on achieving universal health coverage 
(UHC). UHC is realised when everyone has access to quality essential health services with 
financial risk protection. Countries should, therefore, measure and track their progress 
towards UHC over time and take appropriate action. Defining an essential health service 
package (EHSP) is the first and crucial step towards UHC progress. In defining an EHSP, 
counties identify the type and mix of health services that respond to their populations’ 
needs. However, there are gaps in evidence regarding Ethiopia’s current UHC status, and 
it had been more than 15 years since the EHSP was defined in Ethiopia. Furthermore, there 
is relatively little national cost-effectiveness evidence available to redefine the EHSP in 
Ethiopia. Therefore, this study aimed to estimate Ethiopia’s UHC service coverage status, 
generate relevant cost-effectiveness evidence and synthesise and describe the methods, 
process and key features of the revised Ethiopian EHSP.  
Methods: This thesis consists of three studies. In Paper I, 16 individual tracer indicators 
that measure a health system’s performance in various domains were selected to measure 
UHC service coverage in Ethiopia. We grouped the tracer indicators into four major 
programme areas (i.e., reproductive maternal neonatal child health [RMNCH], infectious 
disease, noncommunicable disease [NCD] and capacity and access), and we constructed an 
overall UHC service coverage index using geometric means. We also estimated the 
subnational level of UHC service coverage. In this paper, various surveys and routinely 
collected administrative data were used. In Paper II, we employed a standardised WHO-
CHOICE generalised cost-effectiveness analysis (GCEA) methodology. Average cost-
effectiveness ratios (ACERs) for 159 health interventions were calculated. The health 
benefits of interventions were determined using healthy life years (HLYs) gained. The 
economic costs of interventions were estimated from the health system perspective. We 
used the OneHealth tool for data analysis. In the third paper (Paper III), we synthesised and 
described the methods, process and critical features of the 2019 EHSP. A total of 35 




consultative workshops were convened with experts and the public to define the revision’s 
scope, develop a list of health interventions, agree on the prioritisation criteria, gather 
evidence and compare health interventions. Seven prioritisation criteria were employed: 
disease burden, cost effectiveness, equity, financial risk protection, budget impact, public 
acceptability and political acceptability. 
Results: The overall UHC service coverage for Ethiopia in 2015 was 34.3%, ranging from 
the highest (52.2%) in Addis Ababa to the lowest (10%) in Afar. The programme area 
coverage varied from about 53% for infectious diseases to 20% for capacity and access 
(Paper I).  
In Paper II, we found ACERs ranging from less than US$1 per HLY gained for family 
planning intervention to about US$48,000 for colorectal cancer treatment at stage 4. About 
75% of all interventions evaluated had ACERs of less than US$1,000 per HLY gained. The 
majority (95%) of RMNCH and infectious disease interventions had an ACER of less than 
US$1,000 per HLY while around half of interventions (44%) targeting NCDs had an ACER 
of less than US$1,000 per HLY.  
In Paper III (EHSP revision process), 1,749 interventions were identified in the first phase. 
These interventions were regrouped and reorganised, and 1,442 interventions were 
identified as possible candidates for the EHSP. In the second phase, we removed 
interventions that did not match the burden of disease or were not relevant in the Ethiopian 
setting, and, therefore, the number of EHSP intervention was reduced to 1,018. We then 
evaluated and ranked the interventions by the other six criteria. In the final EHSP, 594 
(58%) interventions were classified as high priority, 213 (21%) as medium priority and 211 
(21%) as low priority. The current policy is to provide 56% of interventions free of charge 
and to ensure 38% on cost-sharing and 6% on cost-recovery arrangements.  
Conclusions: In conclusion, the baseline (2015) UHC service coverage index for Ethiopia 
was low. Furthermore, several potential cost-effective interventions were available that 
could substantially reduce Ethiopia’s disease burden if scaled up. The revision of Ethiopia’s 




EHSP followed a comprehensive, participatory, inclusive and evidence-based process, and 
the EHSP interventions were linked to appropriate health care delivery platforms and 
financing mechanisms. 
Keywords: Universal health coverage, cost-effectiveness analysis, priority setting, 
Ethiopia, essential health services package, equity, financial risk protection  
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Chapter 1. Introduction 
1.1 Background  
Several organised attempts have been made to promote the health of people globally. In 
1948, the World Health Organization (WHO) in its constitution defined health in a very 
broad sense as ‘a state of complete physical, mental and social wellbeing and not merely 
the absence of disease or infirmity’ (1). This definition is crucial as it introduced a social 
model of health as a new paradigm (2). In 1978, 30 years later, Member States of the United 
Nations (UN), convened in Alma-Ata, reaffirmed this definition of health and endorsed a 
primary health care (PHC) strategy to achieve ‘health for all by the year 2000’ (3). PHC is 
defined as ‘essential health care based on practical, scientifically sound and socially 
acceptable methods and technology made universally accessible to individuals and families 
in the community through their full participation and at a cost that the community and 
country can afford’ (3).  
The PHC strategy brought important principles into perspective, such as health as a human 
rights issue, the multi-sectoral concept of health, community ownership and active 
participation in policymaking (3, 4). Furthermore, PHC emphasises bringing health care 
close to where people live and work (2). However, PHC was not fully implemented because 
of poor leadership at the country level, lack of coordination at the global level, a shortage 
of health workforce, inadequate funding, a large urban-rural gap and the emergence of new 
infectious diseases (IDs) (4, 5). 
In 2000, the UN convened countries, donors and the development community around eight 
goals to be achieved by 2015: the Millennium Development Goals (MDGs). Three of the 
goals pertained directly to health, and most of the other goals were related to health (6). 
Although many MDGs were not achieved, a tremendous improvement was recorded in 
reducing maternal and child mortality as well as in reducing the malaria, TB and HIV 
burden (7). The MDGs’ health goals were criticised for being disease-specific, 
unsustainable and lacking a system-strengthening component (8). Furthermore, almost half 




the world’s population cannot access essential health services, and about 100 million people 
are forced into extreme poverty annually because of medical expenses (9). The proportion 
of people facing catastrophic financial hardship due to out-of-pocket spending on health 
care (i.e., spending more than 10% of their total income for health care) increased from 
2.7% in 2000 to 3% in 2010 (9). This contributed to developing a more comprehensive goal 
by the UN: the Sustainable Development Goals (SDGs). In 2015, all countries signed on to 
the SDGs. The third goal on health is to ‘ensure healthy lives and promote wellbeing for all 
at all ages’. To achieve this goal, universal health coverage (UHC) emerged as an 
overarching target (Target 3.8).  
This chapter, therefore, concentrates on the theoretical and empirical evidence around 
UHC—what actions can be selected to progress towards UHC at the country level and how 
to quantify progress towards UHC service coverage—with a particular focus on defining 
an essential health service package (EHSP) in the low- and middle-income countries 
(LMICs) context. I conclude this chapter by providing the rationale for the studies included 
in this thesis. 
1.2 What is UHC? 
There is a growing consensus on the importance of UHC globally. Both WHO and the 
World Bank (WB) have placed UHC at the top of their health sector agenda for the past 15 
years. For instance, Margaret Chan, former WHO Director-General, called UHC ‘the single 
most powerful concept that public health has to offer’. There is also strong enthusiasm and 
political commitment for UHC in most of the Member States. Nonetheless, there was no 
explicit understanding of the definition, conceptual framework and scope of UHC for many 
years, and thus its meaning evolved through several readings by various systems.  
The most frequently cited interpretations of UHC are those provided by WHO in its 2008 
and 2010 World Health Reports (WHRs), which state that UHC is achieved when ‘all 
people and communities can use the promotive, preventive, curative, rehabilitative and 




palliative health services they need, of sufficient quality to be effective, while also ensuring 
that the use of these services does not expose the user to financial hardship’ (8, 10). This 
definition entails that UHC can be viewed from three interconnected dimensions: 
population coverage, service coverage and financial security (Figure 1). The service 
coverage dimension examines which health interventions should be provided first. The 
population coverage dimension explores what proportion are covered. The financial 




Figure 1. The three dimensions of UHC (Source: World Health Report 2008 and 2010) (8, 
10). 
1.3 What can be done to progress towards UHC? 
In the 2010 WHR, WHO posed three fundamental questions: How should countries finance 
UHC plans? How should countries limit the financial risk of their people due to medical 




reasons? How should countries encourage the optimum use of available resources for 
health? Following that report, various proposals have been put forward on UHC. In 2014, 
the WHO Consultative Group on Equity and Universal Health Coverage, in its final report 
entitled ‘Making Fair Choices on the Path to Universal Health Coverage’, published a new 
priority-setting framework and recommended a three-layer solution to progress towards 
UHC at the country level (11). According to WHO, categorising health services into various 
priority groups should be the first step to identify high-priority interventions explicitly. As 
no country can afford to deliver the whole list of health services, prioritising health service 
is an inevitable, critical and essential step (11). I further expand on this point in the next 
subsection. 
Expanding coverage for those high-priority interventions to everyone is a second step. This 
can be achieved by eliminating out-of-pocket payments (OOPs) through increasing 
mandatory prepayment mechanisms (i.e., insurance). The third step based on WHO’s 
recommendation is to bring disadvantaged groups into consideration (i.e., economically 
poor, rural populations, etc.) and to expand their coverage (11). 
 
1.4 Identifying priority services for UHC 
The rapid expansion of advanced health technology has been seen worldwide, resulting in 
improvements in human wellbeing. This fast expansion of health care technology is also 
associated with an increased cost of health service delivery while available resources are 
always limited (12, 13). Therefore, no country in the world can afford to provide all services 
to the whole population in a sustainable manner. Identifying priority services that can be 
realistically delivered is one of the vital steps on the path towards UHC at the country level.  
There are two key priority-setting approaches. The first approach is a priority setting using 
health technology assessment (HTA) platforms. HTA refers to ‘a systematic evaluation of 
properties, effects, and impacts of health technology’(14). HTA can identify priority 




services by comparing interventions in terms of their health, societal and economic impacts. 
HTA is the predominant mechanism of priority setting in most high-income countries (14). 
The National Institute for Health and Care Excellence in the UK is the outstanding HTA 
platform example. Recently, there is also growing demand for establishing HTA bodies in 
many LMICs. The Health Intervention and Technology Assessment Programme in 
Thailand is an excellent model of this. However, priority setting using the HTA approach 
is often conducted for a single health technology at a time. Therefore, it is costly, time 
consuming and not practical for evaluating an extensive list of health interventions for 
UHC-type reform.  
The second priority-setting approach defines an essential health benefits package or EHSP.1 
This approach is more appropriate for UHC-type reform that involves evaluating large sets 
of health interventions in the health sector. EHSP revision enables evaluating large sets of 
health interventions in a relatively shorter time than the HTA process. The EHSP revision 
process is conducted periodically (i.e., often in five- or 10-year intervals) while HTA is a 
one-by-one continuous evaluation process. Therefore, the EHSP process is a predominantly 
preferred approach in many LMICs.  
1.4.1 Priority-setting frameworks for designing an EHSP 
Priority setting is a complicated exercise that requires theoretical and empirical analysis of 
the health system from political, economic, social and environmental perspectives. Various 
important frameworks have been developed and proposed for different contexts to navigate 
this complexity, but there is yet no single widely accepted framework (15-18). This 
subsection briefly describes three of the more prominent frameworks applicable to low- and 
middle-income settings from the perspective of the EHSP revision process. 
In the 1993 World Development Report, Jamison et al. provide the disease control priority 
(DCP) framework for selecting and ranking health services based on a combination of 
 
1 Ethiopia chose the second priority-setting approach (defining an EHSP). A detailed description of the Ethiopian 
EHSP revision approach is included in Chapters 2–6.   




disease burden and economic evaluation (cost effectiveness). According to Jamison et al., 
all health problems should be ranked based on the disease burden they place on the 
population (i.e., total disability-adjusted life year [DALY] losses), and the corresponding 
available interventions for each problem should be ranked based on cost effectiveness (i.e., 
DALY averted per dollar spent). Priority should then be given to those health problems for 
which cost-effective interventions are available that can minimise DALY loss. Jamison et 
al. further argue that, if a particular health problem causes many DALY losses, it should be 
a priority for research on the development of cost-effective interventions. Therefore, DCP 
formally introduced economic evaluation as an essential tool for prioritising health 
intervention and disease control programmes in LMICs (19, 20).  
DCP-1 and DCP-2 have been criticised for showing less concern for the distribution of the 
health benefits from the interventions across the socioeconomic gradient (21). However, in 
the third edition (DCP-3), this framework has quickly evolved, and it includes other vital 
dimensions using an extended cost-effectiveness analysis (ECEA) approach. ECEA is an 
expansion of standard cost-effectiveness analysis (CEA) that enables evaluating financial 
risk protection (FRP), equity impact, death averted and poverty cases averted by the 
interventions in addition to costs and health benefits. Furthermore, DCP-3 brought together 
more than 500 scholars and proposed 21 essential universal health packages (EUHCs) 
appropriate to LMICs that contain 218 promotive, preventive, curative, rehabilitative and 
palliative interventions. These packages also include intersectoral and health-system 
level interventions. DCP-3 proposed a subset of 108 interventions as a ‘highest priority 
package’ that needs particular attention to be implemented as a first step towards UHC for 
rapid population health improvement (19, 22).  
Glassman et al., in a seminal paper, provide another priority-setting framework, which 
argues that all interventions should be compared, ranked and selected based on their ‘value 
for money’ from a broader societal perspective (23). The central element in this framework 
is ‘value’, which may vary from society to society and from time to time. On this 




framework, Glassman et al. provide 10 core steps for revision of an EHSP that fit nicely in 
the classical policy cycle of planning (Steps 1–7), implementation (Steps 8–9) and 
evaluation (Step 10) (Figure 2) (23). According to this framework, defining the priority-
setting exercise goal is the first and most crucial step in the EHSP revision process. This 
step helps to ensure that coherence in the whole process can be maintained. Defining an 
appropriate goal is fundamental for installing accountability mechanisms as it helps 
determine whether the EHSP responds to what it initially intended to achieve (23).  
According to Glassman et al., defining methods and prioritisation criteria for appraisal, 
choosing the package outline and selecting areas for further analysis are essential steps. 
Other crucial steps in EHSP design include collecting evidence, understanding appraisal 
and budget impact assessment, deliberating on evidence, making recommendations and 
taking decisions, translating decisions into resource allocation and use and implementing 
and managing the EHSP. Reviewing and learning should be integral parts of the design 
process as they pave the way for improvement in the next round of revision with a new 
goal. Furthermore, the context (i.e., political institutions, health systems, markets, rights, 
technology, the economy) in which the EHBP design is conducted is a crucial element to 
be considered (Figure 2) (24).  





Figure 2. Core elements of defining an EHSP (Source: Modified from Glassman et al. 
(23)). 
In 2014, the WHO Consultative Group on Equity and Universal Health Coverage provided 
another priority-setting framework stating that UHC-oriented EHSPs at the country level 
should evolve through continuing dialogue with all stakeholders using quantitative and 
qualitative criteria (11). The Consultative Group proposed that priority should be given to 
those interventions that are very cost effective and whose implementation would result in 
higher FRP and reduced inequity. This framework provides major priority-setting criteria 
(cost effectiveness, priority to the worse off and FRP) and discusses the relevance of 













1.4.2 Priority-setting criteria  
In defining an EHSP, the gap between what is affordable and what is ideal is challenging. 
Reconciling aspirational policy targets with existing available resources is one of the central 
goals in revising the EHSP in many countries. The challenge is enormous in a low-resource 
setting with minimal financial and technical capacities. Therefore, hard decisions using 
multiple criteria, each representing different values, must be made.  
Various criteria have been used in diverse settings to compare and rank health interventions 
and technologies differently. Some of the criteria are associated with the interventions’ 
characteristics (e.g., cost effectiveness, effectiveness). In contrast, some others are 
associated with the health problem/disease (e.g., disease burden, severity, FRP) and the 
characteristics of the targeted beneficiaries (e.g., income, age, sex, residence). Systematic 
reviews identify that CEA is the most frequently used criterion in diverse settings, followed 
by severity, equity, FRP and budget impact (25, 26). I briefly describe the more common 
criteria (i.e., cost effectiveness, severity, equity, FRP, budget impact). Furthermore, public 
and political acceptability are usually considered in priority-setting exercises—implicitly 
or explicitly (27, 28). 
Cost effectiveness  
Economic resources are finite while population health demands are enormous. Therefore, 
cost is the primary input to the decision-making process in any health care system. Because 
of budget constraints and continued increases in costs in many countries, cost effectiveness 
has become an essential guiding principle in priority setting. Many leading health 
economists and ethicists agree that the cost-effectiveness criterion should be a centrepiece 
of priority-setting analysis as the opportunity costs of ignoring this criterion, in terms of 
health benefits forgone, could potentially be huge (29, 30). Hence, a comparison of the 
costs of including additional health interventions with their health benefits is key to 
decision-making. CEA is a type of economic evaluation that compares two or more health 
interventions based on both cost and health benefit (31). 




CEA has two fundamental approaches: marginal/incremental CEA, which uses an 
incremental cost-effectiveness ratio (ICER), and generalised CEA (GCEA), which uses an 
ACER to compare the added value of the intervention with its associated cost (Figure 3). 
The ICER reports the ratio of the change in the cost to the change in health benefit. 
𝐼𝐶𝐸𝑅 =
[𝐶𝑜𝑠𝑡 𝐴 −  𝐶𝑜𝑠𝑡 𝐵]
[𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑛𝑒𝑠𝑠 𝐴 − 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑛𝑒𝑠𝑠 𝐵] 
 
where ICER is incremental cost effectiveness for Intervention A compared with 
Intervention B and where Cost A, Cost B, Effectiveness A and Effectiveness B represent 
costs and effectiveness for interventions A and B, respectively. 
Incremental CEA compares the cost effectiveness of adding new interventions against the 
current best practice (32). ICER is the most widely used measure in the economic 
evaluation literature, and it is an appropriate measure for HTA settings where the aim is to 
evaluate a single or a few closely related interventions compared with the current best 
available alternative (33). However, the incremental approach assumes that the current 
practice is organised in the most efficient way possible. Therefore, it does not account for 
existing inefficiencies in the health system, and it is difficult to examine whether the current 
mix of interventions represents an efficient use of resources (32, 34).  
GCEA is one form of CEA that compares interventions with a ‘doing-nothing’ scenario 
(32). The ACER captures the average cost per health benefit (i.e., ACERA = COST A / 
Effect A) (35, 36). GCEA was proposed and developed by WHO’s CHOosing Interventions 
that are Cost Effective (CHOICE) programme (34, 37). This approach assesses whether the 
current mix of interventions is efficient and whether a proposed new technology or 
intervention is appropriate. For EHSP revision and other sector-wide CEAs of wide ranges 
of interventions from multiple programme areas, GCEA is a preferred approach (34).     





Figure 3. ICERs in the incremental analysis (A) and ACERs in the GCEA (B) (Source: 
WHO; hypothetical example modified by the author). 
Severity 
Concern about health problems or conditions that cause severe illness to an individual or a 
society at large is an important matter to consider in resource allocation decisions (38, 39). 
Therefore, severity criteria are applied in many priority-setting processes, in both high- and 
low-income settings, to compare both interventions and diseases (40-42). For example, in 
Norway, ‘severity of disease’ has been used in priority setting since 1987 (43-45). Severity 
criteria have also been applied in priority setting in many LMICs (41, 42, 46). 
Severity can be measured using burden of disease data employing an ‘average age at death’ 
(AD) parameter. It is also desirable to include morbidity in many cases, and this measure 
is called ‘health-adjusted age of death’ (HAAD).2 Practically, we assign additional weights 
 
2 To compute HAAD, data on cause-specific incidence, prevalence, average disability and mortality as well as all-
cause mortality and average population disability can be taken from the Global Burden of Disease Study. To 
calculate condition-specific HAAD, a cohort of individuals is created for each health condition such that the age 
pattern reflects the condition-specific incidence. This cohort is then exposed to with-condition mortality risk for a 
certain length of time depending on the condition, after which they are exposed to the general population mortality 
risk. For some conditions, the elevated mortality risk is lifelong. Using standard life table methods, the deaths can be 
counted by age. The years lived are then adjusted based on the population average disability in years lived without 
the condition and on the background disability and condition-specific disability for years lived with the condition. 
                                                                                                                     
                        






   
   
   
   
   
       
  
  
   
  
 
                             






   
   
   
   
   
       
  
  
   
  
 
                             




according to who are worst off in terms of lifetime health (AD or HAAD). Conditions and 
corresponding interventions can be graded, for example, on a scale of 1 to 4 based on 
HAAD cut-offs of fewer than 30 years (worst) and greater than 60 years (best) (47, 48). 
Equity 
Prioritising health interventions based solely on cost effectiveness may not always be 
aligned with the public view of fair health services distribution. In deciding whether to 
include a specific intervention in the health service package, policymakers should carefully 
consider the interventions’ equity impact. People living in poverty and with severe diseases 
are more likely to have poor health than others, which can be captured by a concern for the 
worse-off, or equity impact (49). Also, health services should be available to every person 
with the same need regardless of socioeconomic status, age, gender or location (i.e., 
urban/rural or across different regions of a country) (50, 51).  
Equity criteria arise from a government’s policy commitment and local social values to 
make a reasonable and just distribution and a pro-poor health system. The equity criterion 
can be applied to give higher priority to health gains from interventions targeting diseases, 
conditions and risk factors that mainly affect the worse off, although the definition of 
‘worse off’ varies from country to country (11, 42, 52). The equity impact of interventions 
can be quantitatively measured using a concentration curve and concentration index (52-
54). 
Financial risk protection 
There is a broad consensus that the FRP criterion should be incorporated in priority-setting 
decisions (11, 55). FRP is defined as households’ ability to obtain health services without 
financial hardship. Financial risk can best be measured using catastrophic health 
expenditures (CHEs). A CHE is defined as total spending per household for a medical 
 
HAAD, then, can be measured in years of the average health-adjusted age at which individuals with a particular 
disease or injury die. 




reason that is greater than 10% of the total income or 40% of non-food expenditure. Large 
OOP medical payments due to illness can cause financial hardship. Health services that 
cause large OOP expenditures to patients and households should be given high FRP weights 
and be considered high-priority interventions (11, 56).  
Budget impact  
A budget-impact criterion helps to compare whether or not any high-impact and cost-
effective interventions are affordability at large scale implementation (57, 58). For instance, 
an Intervention A may be attractive in terms of CEA with an ACER of US$50 per DALY. 
If the implementation of Intervention A (e.g., influenza vaccination) in Ethiopia cost US$1 
per person per year, US$55 million per year is needed if the intervention is to be delivered 
to 50% (approximately 55 million) of the population. A hypothetical Intervention B (e.g., 
HPV vaccine) that is relatively less cost effective compared with Intervention A, with an 
ACER of US$100 per DALY averted, may cost US$10, so US$5 million is needed if the 
intervention is to be delivered to all 13-year-old girls (approximately 500,000 population). 
Therefore, budget impact criteria facilitate the comparison of interventions beyond cost-
effectiveness criteria in terms of affordability compared with the available budget. The 
available budget determines the final set of services to be provided (58). 
1.4.3 Deliberation and decision process  
Priority setting is a value-based and political process that tries to harmonise the divergent 
values, needs and interests of people, individuals, groups and patients (59). Therefore, 
priority setting in the design of an EHSP should be democratic, open and participatory 
(involving wide ranges of stakeholders) (60, 61). In benefit package design, one of the early 
and exemplary processes of open public deliberation is the case of the Oregon Health Plan 
(62). In the Oregon Health Plan, the state invited people to prioritise the medical conditions 
covered by the heath benefit package in an open, deliberative process (63).  
Amongst both researchers and policymakers, there is a growing consensus on the value of 
deliberation and public participation in priority setting (15, 64, 65). Daniels and Sabin 




proposed a widely known framework, accountability for reasonableness (A4R), to make 
the deliberation process legitimate and fair (66). According to A4R, the following four 
conditions should be fulfilled to conduct legitimate and fair prioritisation processes: 
relevance, publicity, appeals/revision and enforcement. Relevance entails that all relevant 
stakeholders should have the chance to participate in the process. Differing views, opinions 
and preferences should be respected. The debates should be based on clear arguments, and 
all involved stakeholders should be given a chance to have a voice. Publicity entails that 
priority-setting decisions and the justifications behind them should be transparent and made 
publicly available. The publicity can be done using media or any other means of 
communication, circulating and posting the meeting agenda and draft reports. Appeals and 
revision entail that all stakeholders should be given a chance to make an appeal against 
decisions, suggest revisions and receive a response. Appeals ensure that people affected by 
the decision have a voice, are adequately heard and are guaranteed a revision procedure. 
Enforcement entails that the first three conditions are appropriately obeyed. This condition 
is crucial, and a legally mandated institution should be in place to implement, monitor and 
ensure that the deliberative process that meets the standards of the four conditions is 
continuously applied (66).  
Combining the more qualitative A4R process and the more quantitative multi-criteria 
decision analysis (MCDA), Baltussen et al. recently proposed a new deliberation 
framework called evidence-informed deliberative processes (EDP) (67). The EDP 
framework’s key feature is the early involvement of relevant stakeholders to identify, 
reflect and learn about relevant values’ meanings and importance. According to EDP, the 
stakeholders’ involvement ranges from identifying prioritisation criteria to technical 
dialogue and decisions for inclusion or exclusion of interventions from the benefits 
package. This can contribute to the legitimacy of final decisions by elected government 
officials (67). Although both A4R and EDP are developed and explored in various HTA 
settings, the four conditions of A4R and EDP are also highly applicable in the EHSP 
revision process (67).  




1.5 Measuring progress towards UHC 
The crucial steps in rapidly progressing towards UHC include measuring the baseline 
status, understanding gaps, taking remedial action along the way, and monitoring 
improvements at the national and subnational levels (68, 69). In this regard, several country-
level and multi-country studies have been conducted to measure the national UHC status in 
diverse countries (70-85). In the past five years, at the global level, WHO, the WB and the 
Institute for Health Metrics and Evaluation (IHME) have made a proposition to formulate 
a comparable UHC monitoring tool/framework using various data sources and 
methodologies (86-88).  
In the first global UHC tracking report, published in 2017, WHO and the WB jointly 
introduced a new UHC monitoring framework (89). According to this framework, the FRP 
element can be measured using both the incidence of impoverishment and the incidence 
financial catastrophe. The service coverage element can be measured using 16 selected 
tracer indicators. The tracer indicators are grouped into four major categories: reproductive, 
maternal, newborn and child health (RMNCH); IDs; noncommunicable disease (NCD); and 
service capacity and access (86). A geometric mean of each tracer indicator can be first 
aggregated for each major group, and then the overall UHC index can be computed by 
taking a geometric of the coverage across the four major groups. According to these metrics, 
the two interdependent UHC sections (i.e., FRP and service coverage) should be measured 
and presented separately. In this report, WHO/WB provide the 2015 UHC service coverage 
status of all UN member countries using only 14 of the tracer indicators (because of data 
limitations) (86). The proposed UHC target in 2030 is achieving 80% service coverage and 
100% FRP; the service coverage baseline ranges from 22% in Somalia to already higher 
than 80% in most OECD countries (86).  
Wagstaff and Neelsen propose another UHC monitoring framework, which uses a single 
index by combining the two aspects of UHC into one (i.e., FRP and service coverage) (88). 
In this model, a weighted geometric average of service coverage and FRP is employed. The 




UHC service coverage index is built using a weighted geometric average of another eight 
tracer indicators (cervical cancer screening, breast cancer screening, antenatal care, full 
immunisation, skilled birth attendance, treatment of acute respiratory infections, treatment 
of diarrhoea and inpatient admissions). The financial risk is measured as the incidence of 
CHE (i.e., those who encounter medical spending exceeding 10% of household income). 
The service coverage part is further divided into prevention and treatment categories. This 
tool also demonstrates how to compute the inequality-adjusted UHC index, considering the 
coverage difference across socioeconomic groups. Wagstaff and Neelsen illustrate the tool 
using empirical data from 111 LMICs, generating a single UHC index for each country that 
ranges from about 35% in Côte d’Ivoire to about 80% in Ukraine (88).  
In 2020, the 2019 Global Burden of Diseases Collaborators on Universal Health Coverage 
introduced a new UHC monitoring tool utilising a weighted average of 23 tracer indicators. 
The 23 tracer indicators were chosen based on WHO’s General Programme of Work 
(GPW13)3 framework, with a design representing effective coverage of promotive, 
preventive and therapeutic services in all age groups. Unlike contact coverage indicators, 
effective coverage indicators capture quality and the services’ outcomes (i.e., mortality 
averted, disease incidence/prevalence reduced, etc.). The group demonstrate the tool using 
global burden of disease (GBD) data from 1990 to 2019 and generate a UHC service 
coverage index for 204 countries and territories, ranging from about 22% in the Central 
African Republic to 96% in Japan (87).  
In general, all three UHC monitoring frameworks consistently employ the incidence of 
impoverishment and financial catastrophe resulting from OOP health payments to measure 
FRP. However, the frameworks vary substantially regarding the measurement of service 
coverage. The variation is due to the number and types of service tracer indicators used, 
how the service types are categorised (inpatient vs. outpatient service or curative vs. 
preventive service) and how they are weighted. Additionally, some key health services 
 
3 GPW13 is https://www.who.int/about/what-we-do/GPW13_WHO_Impact_Framework_Indicator_Metadata.pdf 




aspects were excluded from the indicators on the grounds of simplicity, comparability and 
information availability in all three frameworks (90). Furthermore, both WHO/WB and 
Wagstaff and Neelsen captured contact coverage rather than effective coverage while the 
recent IHME measure employed effective coverage, which accounts for the quality of 
service delivered (86, 87). 
1.6 Overview of the Ethiopian health system  
Ethiopia is the second-most populous country in Africa, with an estimated population of 
about 110 million in 2020. Nearly 85% of the population live in rural areas and are 
dependent on subsistence agricultural. Despite fast economic growth in the past 15 years, 
with an average growth rate of 8% annually, Ethiopia is still one of the low-income 
countries, with a per capita income of US$953 in 2019. About one-fourth of the population 
live with an income that is below the poverty line (91). Ethiopia is a federal state organised 
into 10 semi-autonomous regions and two chartered cities (Addis Ababa, the capital, and 
Dire Dawa). The regions are divided into zones and districts (woreda). The woredas are 
further divided into villages (kebeles). Kebeles are the smallest administrative unit.  
Section 1.6.1 briefly describes major milestones, policies and strategies in the Ethiopian 
health system in the past 100 years, prior to the health sector transformation plan (HSTP). 
Section 1.6.2 briefly describes the Ethiopian health system’s status using the six health 
system building blocks.  
1.6.1 Some historical perspective 
Ethiopia is an ancient independent country with its own medical tradition for millennia. 
However, the people have been deeply interested in modern health services for centuries 
(92, 93). The establishment of the first hospital in Addis Ababa by the Russian Red Cross 
Society in 1909 (94), the ratification of the Public Health Proclamation in 1946, the 




establishment of the Ministry of Health (MOH) in 19484 and the founding of Gonder Public 
Health College and Training Center (GPHC&TC) in 1954 can be mentioned as significant 
milestones in the progress of the Ethiopian health system from traditional medicine to a 
modern health system. The 1946 proclamation established legal grounds for 
institutionalising health departments at national, provincial, and sub-provincial (Awraja)5 
levels. The college trained health officers, community nurses and sanitarians to staff 
provincial health centres. This played a pivotal role in expanding health service and greatly 
increasing the number of health professionals (95-97).  
In the 1960s, the first national health policy/strategy was formulated as part of the Second 
Five Year Plan (1963–1967). The central objective of this strategy was to meet the health 
needs of rural populations. It was targeted to expand health centres and health stations (with 
one health centre serving 50,000 people and supervising 10 health stations). Although this 
strategy contributed to some extent to an increased access to essential health services 
through expansion of health facilities (i.e., hospitals, health centres, health stations) and the 
integration of preventive and curative services, the main objectives were not fully realised 
because of a critical shortage of health workers, drugs, medical equipment and supplies; an 
inadequate supervision, communication and referral system; underutilisation of the capital 
budget; and an insufficient recurrent budget (96-99).  
In the Third Five Year Plan (1968–1972), the focus was mainly on malaria elimination and 
on vertical programmes, such as TB, malaria and leprosy. However, the implementation 
was fundamentally problematic because it focused mainly on building and running 
hospitals in major cities. For instance, in 1974, there were 6,474 health personnel of all 
types, 650 health stations, 93 health centres and 84 hospitals (with 8,624 beds). About 43% 
 
4 After independence from the Italian occupation, from 1941 to 1946, the public health service in Ethiopia was 
administered by the Department of Public Health within the Ministry of Interior.  
5 Awraja (Amharic: አውራጃ) is roughly translates to "county" or "sub-province" that contained a number of 
districts prior to 1996.  




of the health budget was allocated to hospitals in three major cities (Addis Ababa, Harar 
and Asmara6) (96, 98, 99). 
When the socialist Derg regime came to power in 1974, there was again an aspiration to 
establish a community-based PHC system. The Ethiopian government warmly welcomed 
the 1978 Alma-Ata Declaration on Primary Health Care and the ‘Health for all by 2000’ 
call (100). A prominent programme that reflected an inter-sectoral and community 
participation approach was the ‘development through cooperation’ (Ediget be Hibiret 
zemetcha) campaigns implemented between 1978 and 1985. In this programme, the 
government sent final-year high school and university students to remote areas to carry out 
development campaigns. Although the campaigns’ scope was much more comprehensive, 
the students were actively involved in various health programmes, ranging from the 
construction of health facilities, communal solid waste disposal pits and latrines to 
traditional birth attendance and health education. The number of health stations tripled from 
650 to 1,950. The number of health centres increased from 93 to 145 (96, 98, 99). 
The ‘development through cooperation’ programme contributed to increased health 
awareness and utilisation of health services. It had little impact in terms of strengthening 
community health more broadly. The ideals of community participation, a vital feature of 
the PHC strategy, were undermined by the regime’s authoritarian structure and the coercive 
nature of the government’s interventions. Therefore, the implementation of PHC policies 
was mostly unsuccessful in Ethiopia, mainly because the specific elements of the PHC 
strategies were not clearly defined at the national level, and administrators of provinces’ 
health departments and experts at health facilities had limited awareness of those elements 
as defined at the national level (98-100). 
In 1984, the MOH launched an ambitious 10-year Perspective Health Plan (1984/85 to 
1993/94) (101). In this plan, a six-tiered health system was introduced with a network of 
community health services (health posts) at the base, health stations (clinics) at the second 
 
6 Asmara is no longer a part of Ethiopia after the secession of Eritrea from Ethiopia in 1993 by referendum.  




level, health centres at the third level, rural hospitals at the fourth level, regional hospitals 
at the fifth level and central referral and teaching hospitals at the top (98-100).  
The 10-year Perspective Health Plan was targeted to extend access to health services to 
80% of the population, reduce the infant mortality rate from 155/1,000 to 95/1,000, reduce 
the crude mortality ratio from 247/1,000 to 95/1,000, improve life expectancy at birth from 
42 years to 55 years and increase the number of health professionals.7 
After the Derg regime was overthrown in May 1991, the Transitional Government of 
Ethiopia (TGE) was immediately established. The TGE ratified a new health policy in 
September 1993 that has 10 basic components, eight priority areas and 17 general strategies. 
This policy’s fundamental motto is ‘prevention is better than cure’, and it highly emphasises 
the importance of health promotion and disease prevention. This policy’s core principles 
are democratisation, decentralisation, collaboration and promoting the private sector’s 
involvement in health service delivery. This policy is still the active health policy of 
Ethiopia.8 To translate this policy into action, a 20-year health sector development plan 
(HSDP) was formulated in 1997.  
The HSDP was in place from 1997 to 2015 and was implemented as four successive five-
year plans (HSDP I–HSDP IV). While HSDP I, HSDP II and HSDP III were aligned with 
the overall government Plan for Accelerated and Sustained Development to End Poverty 
(PASDEP) at the national level and the MDGs at the global level, HSDP IV was aligned 
with the national Growth and Transformation Plan I (GTP I) at the national level (Figure 
4). Notable achievements during the HSDP period include, but are not limited to, the 
accelerated expansion of health infrastructure, the institutionalisation of the health 
extension programme (2003), the defining of the EHSP (2005) and the accelerated 
 
7 The plan was to increase all medical doctors from 721 to 2,000, specialists from 349 to 819, nurses from 1,960 to 
5,498, sanitarians from 298 to 1,962, laboratory technicians from 425 to 1,209 and health assistants from 6,991 to 
13,500. 
8 The revision of the health policy was initiated in 2015. 




expansion of human resources for health (102-105). Figure 4 outlines significant 
developments and events in the Ethiopian health system as of 1993. 
 
Figure 4. Overview of the Ethiopian health system (1993–2020) (Source: Compiled by the 
author). GTP = Growth and Transformation Plan; HSDP = health sector development plan; HEP 
= health extension programme; HRH = Human Resources for Health; UHC = universal health 
coverage; EHSP = essential health services package. 
 
In summary, despite all the remarkable results in the country in the past 100 years, the 
people of Ethiopia are still suffering from a massive burden of diseases from 
communicable, maternal, neonatal and nutritional disorders (CMNND). The magnitude of 
NCDs and injuries is rising, and both the coverage of essential health services and health 
service utilisation are low (106). There is also high catastrophic out-of-pocket health 
spending for health in Ethiopia (107-109).  
1.6.2 Overview of the Ethiopian health system during HSTP I 
In the HSTP I period, Ethiopia has been expanding health service coverage to mental health, 
NCDs and injury beyond the communicable disease and maternal and child health 
programmes. The HSTP period is 2015–2020 (110). 
Health status  
Ethiopia has undertaken significant efforts in improving the health of its people. There has 
been a remarkable result registered in terms of reducing morbidity and mortality (111). 
Ethiopia’s life expectancy improved from 38 in 1960 to 47.1 in 1990, 65 in 2015 and 66.2 




in 2018 (112). Maternal mortality declined substantially from 676 per 100,000 live births 
in 2011 to 420 in 2016. Modern family planning methods utilisation increased from 6% in 
2000 to 35% in 2016. Demand for family planning increased from 45% to 58% in the same 
period (113). Similarly, the morbidity and mortality of IDs, such as HIV/AIDS, TB and 
malaria, has markedly decreased in the past decades (113, 114). However, Ethiopia is one 
of the countries with a high disease burden, even compared with other low-income 
countries, with an age-standardised DALY loss of 47,099 per 100,000 population in 2017. 
CMNNDs represent the highest disease burden, accounting for 58% of the DALY loss. In 
the same year, while NCDs, such as cardiovascular diseases, diabetes and cancer, accounted 
for 34% of the total DALY loss, injuries accounted for about 8% of the total (115).  
Health service delivery 
Ethiopian health service delivery is organised in a three-tier health care system. In general, 
the primary level of care comprises a primary hospital (covering 60,000–100,000 people), 
health centres (covering 25,000–40,000 people) and their five satellite health posts 
(covering 3,000–5,000 people). The secondary level of care consists of a general hospital, 
covering a population of 1.0–1.5 million, while the tertiary level of care consists of a 
specialised hospital serving 3.5–5.0 million people. Each level of care is connected to the 
next level through a referral linkage mechanism (Figure 5). 





Figure 5. The Ethiopian three-tier health system (Source: HSTP 2015). 
Health workforce 
The availability of a sufficient health workforce with the right skill mix is critical to the 
achievement of UHC in any country. Despite the efforts made in the past 20 years to 
increase the number of low- and mid-level health professionals in Ethiopia, the country is 
known for having a very small health workforce by any standard. For instance, the health 
workforce density index, which is measured by the sum of skilled health professionals 
(health officers, medical doctors, nurses and midwives) per 10,000 population, is 0.96 while 
the figure is 2.2 for the rest of Africa, and the WHO recommendation is 4.45 if a country is 
to meet the SDG health targets (116-120). 
Health information systems 
Accurate, reliable and timely information is vital in effectively leading the health system 
with the right evidence. By the end of 2013, a health management information system 
(HMIS) had been implemented in 98% of public hospitals and 87% of health centres. 
Additionally, over 60% of facilities employed a full-time HMIS focal person, which 
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improved the completeness and timeliness of health reports (121). Subsequently, Ethiopia 
introduced a new district (woreda) -based planning process that utilises the facility-level 
data now available via the HMIS to plan future spending and management according to 
facility-specific needs (122).  
Health financing  
The government of Ethiopia has implemented several strategies, including the provision of 
high-impact interventions free of charge through an exemptions programme, subsidisation 
of more than 80% of the cost of care in government health facilities, implementation of 
community based health insurance (CBHI) schemes and full subsidisation of the very poor 
through fee waivers for both health services and CBHI premiums (123-125). Despite these 
efforts, direct household payment to facilities during service use remains unacceptably 
high. According to National Health Account 7, out-of-pocket spending on health amounted 
to 31% of total health expenditure (THE) in 2016/17, considerably higher than the global 
recommended target of 20% (107). A significant proportion of households (4.2%) face the 
effect of CHEs (108).  
Ethiopia’s THE was estimated at ETB72 billion (US$3.1 billion) in 2016/17, accounting 
for 4.2% of the country’s gross domestic product (GDP). The THE has grown steadily since 
1995/96. It grew by 45% from ETB49.6 billion in 2013/14 to ETB72.1 billion in 2016/17 
(107). However, this growth was 15% in real terms after adjusting for inflation. 
Furthermore, the GDP share is lower than the expected average of 5% for low-income 
countries and below the global average of 9.2% (107). 
The share of government contribution to THE was 32% in 2016/17, only slightly higher 
than the 30% contribution in 2013/14. The share of government health expenditure was 
1.4% of GDP in 2016/17, lower than the low-income country average of 1.9% for the same 
year (107). PHC providers, including primary hospitals, health centres and health posts, 
received more than 61% of total government recurrent expenditure. Seventy percent of 
Ethiopia’s government health spending goes to infectious/parasitic diseases, reproductive 




health and nutritional deficiencies.  The average health expenditure per capita is US$33 as 
compared to a regional average of US$38 (107).  
Health system governance  
The health governance system in Ethiopia is a mirror of the broader political system of the 
country. The MOH is mandated to formulate policies, strategies and standards in 
consultation with regional health bureaus (RHBs). The RHBs focus mostly on the 
implementation of programmes and projects and developing directives and manuals. 
Therefore, the MOH is responsible for developing the national health policy and defining 
the EHSP and health sector transformation plans. The Executive Committee (EC) at the 
MOH level is the highest decision-making body in the health sector at the federal level 
(105, 110).  
The governance and decision-making roles are decentralised at various levels from national 
to RHBs and from regions to district health offices. For instance, the Joint Steering 
Committee (JSC) is a forum that brings together critical policymakers at the federal and 
regional level. The minister of health chairs the JSC meeting, and the participants include 
the state ministers of health, RHB heads, deputy RHB heads and the heads of 
departments/services of the MOH and the RHBs. The JSC meets every two months (105, 
110).  
Another national-level governance structure is the Joint Consultative Forum (JCF). The 
JCF is the highest governance body that decides, guides, oversees and facilitates the 
implementation of strategic plans in the health sector. It also serves as a dialogue and 
consultation forum on the overall policy direction, reform and institutional issues of the 
health sector between the government, development partners and other stakeholders. The 
MOH chairs the JCF. Its members include high-level representatives of the relevant federal 
government bodies, representatives of multilateral and bilateral development partners and 
non-governmental organisations (NGOs) that work on health and nutrition and 
representatives of the private sector and health professionals’ associations. There is also the 




Joint Core Coordinating Committee (JCCC), which is a technical arm of the JCF. The JCCC 
mainly support the JCF on technical issues, such as coordination, implementation, evidence 
generation and evaluation (105). Furthermore, the governance system comprises 
consultation forums that facilitate collaborative decision-making processes with 
stakeholders, such as all citizens, NGOs and development partners (105, 110).  
1.7 Recent efforts to progress towards UHC in Ethiopia 
There is strong political commitment and aspiration in the Ethiopian government to 
achieving UHC (110). In the past decades, several efforts to progress towards UHC in 
Ethiopia have been made. I will describe two prominent recent cases that indicate the 
commitment of the government to UHC. The first prominent progress towards UHC 
happened in 2015 when, considering the country’s national goal to reach lower–middle-
income status by 2025 and upper–middle-income status by 2035, the federal MOH 
conducted an ‘envisioning exercise for the health sector’ (126). The envisioning team 
analysed the experiences of various poorly and well-performing middle-income countries 
and produced a strategy to guide Ethiopia’s progress towards UHC, entitled Envisioning 
Ethiopia’s path towards universal health coverage through strengthening primary health 
care (126, 127). The strategies include defining the EHSP of the country, identifying priority 
health interventions, deciding on the payment mechanism (exempting or cost-sharing) for 
high-priority interventions and increasing domestic resource mobilisation, including the 
expansion of CBHI and social health insurance programmes (126, 127).  
The other prominent action on the path towards UHC in Ethiopia was that the MOH clearly 
articulated the priorities on which the Ethiopian government wants to focus to facilitate 
progress towards UHC: (1) defining a cost-effective package of essential health benefits 
available to all; (2) developing investment plans for the physical and human infrastructure 
needed to deliver benefits; (3) developing a national health financing system; (4) 
developing integrated multi-sectoral planning and implementation of health and non-health 
interventions at the district level (128). Additionally, the establishment of the health 




insurance agency and the formulation of new health care financing strategies to alleviate 
financing and service delivery challenges can be mentioned to indicate the Ethiopian 
government’s commitment to progress towards UHC (129).  
1.8 The rationale for the revision of the Ethiopian EHSP 
Changes in health care demand, epidemiologic and demographic transitions and economic 
growth were the main justifications for revising the 2005 Ethiopian EHSP. The Ethiopian 
government has conducted successive reforms based on the country’s formulation of health 
policy. First, the 20-year strategic plan named HSDP, implemented in four phases, was 
developed; each phase had a five-year implementation period. In the implementation of 
HSDP I, there was a gap at the grassroots level, and it was recommended to train community 
health workers; a health extension programme was launched by the year 2003. The 
Ethiopian Health Extension Programme (HEP) was an innovative programme that resulted 
in remarkable improvement in the rural population’s health status by using a community-
based approach delivered by health extension workers. Because of the HEP, the public’s 
awareness of health and hygiene has substantially increased, contributing to increased 
health-seeking behaviour and health service demand (130).  
Second, selecting high-impact interventions was mandatory, and the 2005 EHSP was 
defined. Since 2005, the country’s epidemiologic and socioeconomic profile has 
substantially changed in many ways. Life expectancy has greatly increased. The incidence 
of NCDs and injuries has increased. For instance, the 2017 GBD study shows that NCDs 
and injuries account for 33% and 8% of the disease burden in Ethiopia, respectively9. 
However, the 2005 EHSP and the entire health sector were configured around managing 
communicable diseases, RMNCH and vaccine-preventable diseases, giving less emphasis 
to NCDs. Therefore, revising the health service package to address the whole range of 
health issues and all age groups was necessary. 
 
9 http://www.healthdata.org/ethiopia  




There has been remarkable economic growth in Ethiopia in the past 15 years. For example, 
over the past 10 years, the annual growth rate has been 10.9%. The GDP per capita has 
increased from US$163  in 2005 to US$953  in 2019 (91). This resulted in increased health 
care resources and the public’s ability to pay for health services. Additionally, economic 
growth, especially initially, may lead to lifestyle changes that may increase NCDs. 
Therefore, a health care package that matches the economic capacity of the country is vital.  
Additionally, Ethiopia, like all other UN member states, by signing on to the SDGs, has 
committed to achieving UHC by 2030. This reinforces the imperative that health services 
needing to be delivered ‘universally’ must be identified. Therefore, the need was highly 
critical for a new health benefits package that would fit the country’s socioeconomic, 
epidemiologic and demographic situation; explicitly identify included interventions based 
on evidence; and accommodate the current global context (i.e., the SDGs).  
Furthermore, in the past 15 years, several new health interventions were included in the 
Ethiopian health system without thorough examination of their merits. Rolling out new 
health interventions in a system without a clear understanding of their added value may 
lead not only to the inclusion of inappropriate interventions but also to excluding vital 
health interventions. Therefore, a consensus was reached to revise the EHSP in 2016, 
preparatory work was conducted in 2017 and the revision was conducted in 2018 and 2019.  
1.9 Rationales of the studies 
For the successful revision of an EHSP, a candid examination of the country’s health status, 
a clear framework, evidence for priority setting and a strong political will to make necessary 
change were critical elements. However, when the work on this thesis started, the available 
evidence in these regards was minimal. Therefore, understanding Ethiopia’s baseline UHC 
coverage was vital to devising an appropriate EHSP and later monitoring the package’s 
implementation. Furthermore, only a few studies were available that measured Ethiopia’s 
UHC service coverage status (86-88). A study by WHO found a 39% coverage for Ethiopia 




(86). However, this WHO study did not provide a subnational service coverage status and 
employed only limited sets of indicators. 
Regarding priority setting for UHC-type reform, except for a few theoretical guides that 
describe how to conduct benefits-package revision, no practical guidance was available that 
could inform policymakers in LMICs. Besides, most EHSP reports from other LMICs did 
not provide an adequate description of the methods employed, the process followed or the 
interventions incorporated, and that information is relevant for transparency and 
replicability purposes (131-146). 
After identifying potentially relevant interventions, large sets of evidence were needed to 
compare the merits and demerits of each of the interventions based on selected criteria in 
the revision of the EHSP.10 As CEA is seen to be a critical priority-setting criterion, cost-
effectiveness evidence is a central element in comparing interventions. However, only some 
studies had been published on the cost-effectiveness evaluation of health interventions in 
Ethiopia (147), and the limited available evidence was mainly produced using incremental 
CEA (148-151). Therefore, we identified critical gaps in knowledge in three unique but 
interlinked areas: First, we estimated the baseline UHC service coverage for Ethiopia. 
Second, we generated cost-effectiveness evidence for large sets of interventions. Finally, 




10 The evidence needed is described in detail in section 1.3. 




Chapter 2. Objectives  
2.1 General objective  
This study aimed to estimate the UHC status of Ethiopia, generate relevant cost-
effectiveness evidence and describe the process of defining an EHSP for the country.  
2.2 Specific objectives 
1. To estimate the 2015 national and subnational UHC service status for Ethiopia 
(Paper I) 
2. To generate average cost-effectiveness evidence (ACERs) for relevant health 
interventions using WHO’s generalised cost-effectiveness approach to revise 
Ethiopia’s EHSP (Paper II) 
3. To describe the revision process, key methodology, stakeholders’ and experts’ 
involvement and the most important features of the new Ethiopian EHSP (Paper III) 
  




Chapter 3. Methods 
This thesis consists of three studies (Papers I–III). Each of the studies is linked to specific 
objectives presented in Chapter 2. This section first provides a general overview of the 
study site (Ethiopia) and the study period. I then present a summary of the study design, 
data and analytic approaches of Papers I and II. Furthermore, I briefly present the priority-
setting methods of the Ethiopian EHSP, including the road map, team organisation, scope, 
identification of candidate interventions and evidence synthesis. A detailed description of 
the methodology is provided in each of the published articles (Annexe 1).  
 
3.1 Study site and settings 
The studies in this thesis were conducted in Ethiopia. To understand either the Ethiopian 
health system or its implications for 
UHC in the country, some 
information about its demographic, 
social, economic and political 
background is essential. Ethiopia is 
in located in the eastern part of 
Africa. Sudan and South Sudan 
bound Ethiopia to the west, Eritrea 
and Djibouti to the northeast, 
Somalia to the east and southeast 
and Kenya to the south. The country 
occupies an area of 1.1 million 
square kilometres. More than half 
the country’s geographic area lies 
above 1,500 m above sea level; the 
highest altitude, at Ras Dashen, is 
4,620 m above sea level and the lowest altitude, at the Dallol Depression, is 130 m below 
Ethiopia Map (Source: CIA world fact book) 




sea level (152). Ethiopia is a federal state organised into 10 regional states and two chartered 
cities, Addis Ababa (the capital) and Dire Dawa (another city in the eastern part). 
Ethiopia is the second-most populous country in Africa after Nigeria, with about 110 
million people (152). The population is characterised by rapid growth (2.6%), a young age 
structure and a high dependency ratio. In 2016, the total fertility rate (TFR) in Ethiopia was 
4.6 births per woman (2.3 in urban areas and 5.2 in rural areas), and the crude birth rate  
was 32 per 1,000 population. The average household size was 4.6 (153).  
Although the Ethiopian economy has been growing fast over the past two decades, the 
country is still one of the low-income countries in the world, with a GDP of US$953 per 
capita in 2019 (91). The country aspires to attain lower–middle-income country status by 
2025 (154, 155). The economy in Ethiopia is predominantly dependent on agriculture, 
which accounts for 34% of GDP. Over two decades, although the total per capita spending 
on health increased eightfold (from US$4.00 in 1995 to US$33.20 in 2016/17), the 
country’s THE remained low compared to that of other countries in Africa. The THE in 
2016/17 was only US$3.1 billion, accounting for 4.2% of GDP (107). Furthermore, the 
recent Covid-19 pandemic has substantially affected the economy (156). 
Ethiopia has substantially progressed towards achieving the MDGs, particularly in hunger, 
gender parity in primary education, child mortality, HIV/AIDS and malaria. Between 2000 
and 2017, Ethiopia’s Human Development Index value increased from 0.283 to 0.463,11 an 
increase of 63.5% yet below the average of 0.504 (153). Improving access to health services 
has been one of the primary agendas during HSDP and HSTP. As a result, noticeable 
improvements have been achieved in various dimensions of access to health and health-
related services (113). 
 
11 http://hdr.undp.org/en/countries/profiles/ETH 




3.2 Study period  
The overall study period of this research was from April 2018 through November 2019. 
Inception meetings were held from May through August 2018 to develop a road map and 
launch the EHSP revision work. These inception meetings aimed to define the end goals, 
set the scope of the revised EHSP and establish a common understanding among all 
stakeholders for the revision process. As a result, a detailed EHSP preparation plan was 
presented at these inception meetings, and an agreement was reached with the stakeholders 
about the goals and scope of the EHSP. The final EHSP was launched on November 19, 
2019 (Table 1).  
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3.3 Study design and data  
There are three prominent designs employed to measure countries’ progress towards UHC 
(86-88). The approach proposed by WHO/WB was employed in Paper I (86). Because this 
approach has been utilised in various countries recently, it is an excellent design for making 
a multi-country comparison. However, this approach measures only UHC contact coverage 
(not effective coverage). Various data sources were used in Paper I. The author used the 
HMIS, the 2016 Ethiopian Demographic and Health Survey (EDHS), the 2015 Malaria 
Indicator Survey (MIS), the NCD STEPS survey and the Service Availability and 
Readiness Assessment (SARA) survey (113, 157, 158).  




There are two principle CEA approaches (i.e., incremental CEA and GCEA). In Paper II, 
we employed a GCEA approach to generate ACERs for 159 health intervention. The 
analysis was done from the health systems’ perspective. The cost information was identified 
and measured systematically from various departments and agencies of the MOH. For 
example, the cost of drugs and supplies was obtained from the Ethiopian Pharmaceutical 
Supply Agency, and the cost of human resource was obtained from the Human Resources 
for Health (HRH) department. The international drug price database of Management 
Sciences for Health was also used for some of the costs of drugs and supplies.  
Data on the effectiveness of the health benefits of the interventions were estimated by 
applying various integrated impact-models of the latest version of Spectrum software. We 
applied the DemProj module to estimate the projected population growth and basic 
demographic parameters. The FamPlan module estimated family planning interventions. 
The AIDS Impact module estimated the impact of HIV interventions, and the impact of TB 
interventions was estimated using the TB Impact module. The LiST module was used to 
estimate the benefit of nutrition, RMNCH and water, sanitation and hygiene (WASH) 
interventions, and the impact of NCD policy interventions and other NCD interventions 
was estimated using the NCD Impact module. We modified the input data from the WHO-
CHOICE GCEA tool to the local context whenever necessary.  
In the third paper (Paper III), which synthesises the methods, process and significant 
features of the revised Ethiopian EHSP, various study designs and data sources were used. 
In general, a sector-wide (comprehensive) analysis of health interventions using both 
qualitative and quantitative criteria for priority setting was employed. An EDP was also 
employed. I co-led and coordinated the whole of the revision process.  
3.4 The EHSP revision process 
Road map and organisation 
The first step in defining Ethiopian’s EHSP was organising a team and defining the revised 
package’s scope. The revision team consisted of a core team and a technical working group 




(TWG). The core team comprised a health systems specialist, epidemiologist and health 
economist while the TWG consisted of about 30 senior experts on various health system 
dimensions. The core team’s responsibilities were to redefine EHSPs, including developing 
a prioritisation protocol, collecting data, synthesising evidence, engaging stakeholders and 
analysing costing and the fiscal space. In comparison, the responsibilities of the TWG were 
to support the core team in the development of the revision road map and the process of 
revising the package. Consequently, a road map of the revision process and the methods to 
be used was developed, presented to the policymakers and approved by the EC of the MOH 
(Figure 6).  
 
Figure 6. Road map for the revision of the Ethiopian EHSP.  
Scope of EHSP 
The national health policy and the country’s SDG-UHC commitment were the bases for 
defining the revision’s scope. The scope addresses four crucial elements of the EHSP. First, 
it was designed to address the Ethiopian population’s health needs across the whole life 
course regardless of income, gender or residence (urban/rural). Second, it was designed to 
be delivered at all service levels (i.e., primary, secondary and tertiary). Third, the package 




was designed to serve for five years (2020–2025). Fourth, it was to include promotive, 
preventive, curative and rehabilitative interventions. 
Identification of relevant health interventions  
To prepare a complete list of interventions, we searched the national health sector plan, 
strategies and national publications along with reviews of the WHO intervention 
compendium (forthcoming)12 and the DCP-3.13 Subsequently, we held a two-day workshop 
with eight subject matter experts from various programme areas, PHC practitioners, doctors 
and specialists, and they proposed all health services relevant to the Ethiopian context to 
identify additional interventions. In this step, we identified all health intervention 
components, including the promotive, preventive, curative and rehabilitative interventions 
relevant to Ethiopia.  
Setting prioritisation criteria  
Based on the data, dialogue and decision, we set our prioritisation criteria. Our approach 
was first to review the literature, national health policy documents and relevant strategic 
health sector documents. Additionally, we considered the criteria for the prioritisation of 
health services recommended by WHO’s Consultative Group on Equity and Universal 
Health Coverage, including maximising the total health gains for a given investment, giving 
priority to health services that target or benefit the less fortunate and providing FRP, 
particularly to the poor (11). We held 10 consultative and deliberative meetings with global 
and local experts, public representatives and professional associations on the proposed 
criteria. Finally, seven prioritisation criteria were selected, namely the burden of disease, 
cost effectiveness, equity, FRP, budget impact, public acceptability and political 
acceptability.  
For the evidence synthesis, we included a comprehensive list of interventions (1,749) that 








interventions to avoid duplication and got a list of 1,442 interventions. We invited various 
directorates of the MOH and subject matter experts to comment on the list of interventions. 
We further compared the interventions with the burden of disease and risk factors of the 
country. After we removed interventions unmatched by the burden of disease or not relevant 
in the Ethiopian setting, the number of interventions was reduced to 1,223. Finally, another 
regrouping and reorganising of health interventions yielded 1,018 interventions ready for 
evaluation and comparison based on the other criteria. 
3.5 Analytic approaches  
We used geometric means to estimate the national and subnational coverage of UHC for 
the country in Paper I. We analysed the service coverage for each programme area. We 
estimated the overall UHC service coverage for the country (national and subnational 
level). One-way sensitivity analysis was also done to determine how the overall UHC 
service coverage index would change because of a change in analysis approach or tracer 
indicators. For instance, we computed the UHC index using the arithmetic mean in place 
of geometric means to determine the analysis approach’s effect on the overall UHC index. 
We also did a sensitivity analysis by reducing one indicator at a time, first removing the 
health service capacity and access variable and then removing the entire ‘health service and 
capacity’ component.  
In Paper II, an intervention’s ACER was computed as a ratio of the intervention’s total cost 
to total healthy life years (HLYs) gained from the intervention. A 100-year time horizon 
was used. Both costs and health benefits were discounted at an annual rate of 3%. All 
ACERs were reported in 2019 US$ per HLY (37).  
For Paper III, inputs from CEA, equity analysis, costing and budget impact analysis and 
fiscal space analysis were employed. A sector-wide CEA integrated ACERs for 144 
intervention from Paper II, 382 interventions from the literature search and others using 
expert judgement for priority setting. CEA for sector-wide priority setting was limited in 
many other settings because of a lack of sufficient data.  




The interventions were first ranked according to cost effectiveness and then adjusted if the 
interventions had a high equity score and FRP score. The scores for equity impact and FRP 
were assigned through the Delphi process with input from subject matter experts, 
professional associations and public representatives. The budget impact and the number of 
interventions a health system needs can depend on the number of individuals in need and 
the intervention coverage. We estimated the population in need using the total number of 
individuals affected by the condition and the proportion of those who needed the 
intervention. Finally, the core team undertaking the evaluation presented the full results to 
policymakers at the MOH to discuss whether to include or exclude specific interventions 
before final approval. The EC of the MOH, the highest level decision-making body in the 
sector, took the final decision (Figure 7). 
 
Figure 7. Evidence synthesis for the revision of the Ethiopian EHSP. 
No predefined cost-effectiveness thresholds were used in Paper II or Paper III. In Paper II, 
we ranked the interventions based on their ACERs. In Paper III, the ACERs were used as 
input to rank interventions while additional information on equity and FRP informed the 
final ranking.  




STATA (Papers I, II and III), MS Excel (Papers I, II and III) and the OneHealth tool (OHT) 
(Paper II) were used for data management and analysis. Table 2 presents the major 
statistical techniques and data sources employed in this thesis. 
Table 2. Summary of analytic approaches and data sources employed in this thesis.  




Geometric mean, principal component 
analysis  
HMIS, EDHS 2016, the 2015 MIS, NCD 
STEPS survey, HRIS, administrative records, 




GCEA, costing, intervention impact 
modelling  
HRH, EPSA, international drug price database 
(MSH), various integrated impact models of 




GCEA, literature review for CEA, Delphi 
process for equity and FRP, costing and 
fiscal space analysis for budget impact 
analysis 
Results from Paper II, literature search, expert 
opinion  
HMIS = Health Management Information System; EDHS = Ethiopian Demographic and Health Survey; MIS 
= Malaria Indicator Survey; NCD STEPS Survey = Noncommunicable Disease STEPwise approach to 
Surveillance; HRIS = Human Resource Information System; SARA = Service Availability and Readiness 
Assessment; EPSA = Ethiopian Pharmaceutical Supply Agency 
 
3.6 Ethical considerations  
This study complied with all basic recommended national and international research ethics 
standards (159). The principal investigators and all the research team strictly followed the 
research ethics standards in Ethiopia and Norway. This study was approved by the 
Institutional Review Board of the Ethiopian Public Health Institute (Ref: EPHI/6.13/607). 
Furthermore, we obtained an official letter of permission from the Ethiopian federal MOH. 
This study did not involve any individual-level data or sensitive patient information. 
 
  




Chapter 4. Results 
4.1 UHC service coverage for Ethiopia (Paper I) 
We aimed to estimate the national and subnational UHC service coverage, which we used 
as a baseline to revise the EHSP of Ethiopia. Additionally, we aimed to determine the 
regional variation as well as the variations among programme areas. 
The Ethiopian national UHC service coverage for 2015 was 34%, with substantial variation 
across regions and programme areas. For example, the overall coverage varied across 
regions, ranging from 52% in Addis Ababa to 10% in the Afar region. The coverage also 
varied across the programme areas, ranging from 20% for service capacity and access to 
53% for ID (Figure 8). There was also variation within the programme areas. For example, 
in the RMNCH programme area, while the service coverage for the immunisation sub-
programme was 53%, it was only 30% for the pregnancy care sub-programme. In the NCD 
programme area, the variation was wider, ranging from 3% for cervical screening to nearly 
100% for the management of diabetes (Table 3). 
 
Figure 8. UHC service coverage indicators by region and programme area, Ethiopia, 2015. 
The sensitivity analysis indicated that the index was sensitive to the selected analysis 
method and the tracer indicators. When we used the arithmetic mean, the UHC index 




increased to 48%. The UHC index was 41% when we removed the ‘health service and 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.2 Generating cost-effectiveness evidence (Paper II)  
In Paper II, we aimed to generate the average cost-effectiveness evidence (ACERs) for 
relevant health interventions using the WHO generalised cost-effectiveness approach in the 
revision of Ethiopia’s EHSP. 
We produced ACERs for 159 EHSP interventions. We categorised the results by using 
US$100, US$500 and US$1,000. Based on this analysis, we found that 58 (37%) of the 
interventions had an ACER of less than US$100 per HLY, 104 (65%) had an ACER of less 
than US$500 per HLY and 119 (75%) had an ACER of less than US$1,000 per HLY gained. 
The majority of RMNCH and communicable disease interventions had an ACER of less 
than US$1,000 per HLY in this analysis (i.e., 97% of RMNCH, 100% of HIV, 100% of TB 
and 40% of malaria interventions) (Table 4) while 44% of NCD interventions had an ACER 
of less than US$1,000 per HLY. 
The ACER for RMNCH interventions ranged from less than 1US$/HLY for family 
planning to US$1,591/HLY for zinc supplementation. The ACER of HIV/AIDS 
interventions ranged from US$13/HLY for anti-retroviral therapy for adult women to 
US$403/HLY for cotrimoxazole for children. The two most cost-effective malaria 
interventions among the four we evaluated in this study were insecticide-treated nets and 
indoor residual spraying, with ACERs of US$79/HLY and US$40/HLY, respectively. In 
contrast, the two least cost-effective interventions for malaria were intermittent preventive 
therapy for pregnant women and treatment of malaria for pregnant women with ACERs of 
US$1,310/HLY and US$1,469/HLY, respectively. In this study, we evaluated 10 TB 
interventions, and all the interventions were very cost effective, with ACERs ranging from 
US$129/HLY to US$163/HLY. The ACERs for NCD policy interventions ranged from 
US$26/HLY for reduction of salt intake by involving industries in reformulation to 
US$9,115/HLY for prevention of hazardous alcohol use using legal enforcement to restrict 
alcohol advertising.  
 





Table 4. Summary of ACERs of the interventions by sub-programme (US$ per HLY).  
 
4.3 Ethiopian revised EHSP (Paper III) 
We aimed to synthesise and describe the revision process and key features (components, 
priorities, delivery level and payment mechanism) of the revised EHSP. The EHSP is a set 
of affordable promotive, preventive, curative and rehabilitative priority health interventions 
provided at all service delivery levels in an equitable, acceptable and sustainable manner 
on the path towards UHC.  
4.3.1 Key features of the EHSP 
Major programme areas and interventions 
The pre-agreed and predefined prioritisation criteria were used to evaluate the final list of 
interventions (1,018). The analysis results were categorised in nine major programme areas 
as shown in the below table. RMNCH accounts for 33%, NCD for 21%, surgical and injury 
care for 18% and the rest of the percentage was for multi-sectoral nutrition interventions, 
Sub-programme Mean <US$ 
1,000 
Median Min Max 
HIV/AIDS 106 100% 34 13 403 
RMNCH 116 97% 37 0.4 1,591 
WASH 122 100% 16 5 451 
Tuberculosis 143 100% 139 129 163 
Nutrition 262 100% 72 31 746 
Cervical cancer 870 77% 111 34 6,534 
Mental health 1,045 75% 185 31 7,610 
Malaria 1,163 40% 1,310 40 2,915 
NCD policy interventions 1,834 69% 437 26 9,115 
Breast cancer 2,157 20% 1,535 366 6,104 
Chronic respiratory diseases 2,307 50% 809 164 8,856 
Colorectal cancer 3,920 18% 4,646 783 5,602 
Overall 1,014 75% 151 0.4 9,115 




major communicable diseases, health education and behavioural change communication 
(BCC), emergency and critical care, neglected tropical diseases (NTDs) and hygiene and 
environmental health services (Table 5).  
Table 5. Interventions by major programme area.  
Major programme areas and sub-programme areas N % 
RMNCH 333 32.7 
NCD 218 21.4 
Surgical and injury care 181 17.8 
Multi-sectoral nutrition interventions 64 6.3 
Major communicable diseases 62 6.1 
Health education and BCC  57 5.6 
Emergency and critical care  39 3.8 
NTDs 35 3.4 
Hygiene and environmental health services 29 2.8 
Grand Total 1,018 100.0 
Level of priority 
The final list of EHSP interventions was categorised into high, medium and low priority 
interventions. Based on this, 549 (58%), 231 (21%) and 211 (21%) interventions were 
categorised as high, medium and low priority, respectively (Figure 9). 




Figure 9. Interventions by level of priority.  
Delivery platforms  
We analysed the list of interventions categorised by the country’s health care delivery level 
system. We categorised at a primary, secondary and tertiary level of delivery. From the 
total, about 60% of the interventions were categorised to be delivered at the PHC level, 
20% were categorised at a secondary level of care and the rest were categorised at the 
tertiary level (Figure 10).  





Figure 10: EHSP interventions by major programme area and delivery platform. 
* Primary care includes community-based interventions, health posts, health centres and 
primary hospitals. 
Payment mechanism  
Of the entire list of interventions, 56% were categorised as exempted services while 38% 
and 6% were categorised as cost sharing and cost recovery, respectively (Figure 11).  





Figure 11. EHSP interventions by major programme area and payment mechanism. 
Implementation strategies  
Developing an implementation strategy is crucial in realising the effective implementation 
of a revised EHSP. An adequately designed implementation strategy is essential for 
instituting an appropriate planning, monitoring and evaluation system. The implementation 
strategy for the Ethiopian EHSP was developed by focusing on 10 critical strategic 
priorities aligned with the existing policy framework. The implementation strategy also 
proposed an institutional arrangement and various stakeholders’ clearly outlined roles and 
responsibilities for the package’s sound, efficient and sustainable implementation.   
Monitoring and evaluation plan 
Developing an appropriate monitoring and evaluation framework is vital in the 
implementation of an EHSP. Based on this, the MOH of Ethiopia had developed an EHSP 
monitoring and evaluation framework. The framework is based on the principles of one 
plan, one budget and one report. This helps the implementation to be very efficient and 
effective by avoiding the duplication of efforts by various actors/stakeholders. It also 




considers the harmonisation of the existing health information system with population-






Chapter 5. Discussion 
In this chapter, I first briefly present the key findings of each paper. I then compare my 
findings with other, similar studies and experiences and present lessons drawn from the 
Ethiopian EHSP revision process. I then present and discuss the limitations of the revision 
process and each of the papers.  
5.1 Discussion of main findings 
The overarching goal of defining the EHSP was to facilitate the country’s progress towards 
UHC by improving its efficiency, equitability and resilience. The studies in this thesis can 
contribute to this goal either by providing an understanding of the baseline service coverage 
for UHC monitoring (Paper I) or through evidence-based priority setting (Papers II and III) 
and enhanced health resource allocation in Ethiopia.  
Low UHC service coverage in Ethiopia 
Paper I specifically estimated UHC service coverage for Ethiopia for the year 2015. We 
found that the overall UHC service coverage was 34%, which is very low compared with 
the 80% target of the SDG by 2030. 
The coverage is low compared with WHO estimates for Ethiopia (39%), the sub-Saharan 
Africa average (42%) and global coverage (64%) (76). It is also low compared with many 
other countries in sub-Saharan Africa (86) (e.g., Tanzania = 39%, Kenya = 57%). Another 
study, in Kenya, reported a service coverage of 42% in 2013. Additionally, we identified a 
substantial variation in service coverage across regions, ranging from 52.2% in the capital 
(Addis Ababa city administration) to 10% in the Afar region. Furthermore, UHC service 
coverage varies substantially across programme areas, ranging from 20% for health system 
capacity and access to 58% for ID. The latest NHA report also indicates that Ethiopia’s 
resource expenditure follows a similar trend, with most of the financial resources allocated 
for ID and RMNCH and only 11.11% of the total heath expenditure allocated for NCD. 
Cost-effectiveness evidence  




In Paper II, we estimated ACERs for 159 unique interventions. Of the 159 interventions, 
we directly used 144 in the priority-setting exercise in the EHSP revision. The large 
majority (75%) of the interventions have ACERs of less than US$1,000. Furthermore, we 
identified substantial variation across programme areas, with most RMNCH interventions 
being very cost-effective while NCD and surgical interventions are mixed (i.e., 95% of 
RMNCH and ID interventions and 44% of NCD interventions have ACERs of less than 
US$1,000). Overall, our results are consistent with studies from other countries (e.g., 
Zimbabwe, Mexico) and other regional and global estimates (149, 160-170). Our findings 
are also the same as Ralaidovy et al.’s findings that three infectious disease interventions 
(i.e., HIV, TB and malaria) were cost effective, with cost-effectiveness ratios of less than 
US$100 per HLY saved for virtually all the interventions included (171). A study 
conducted in Argentina shows that the average cost effectiveness per DALY for various 
interventions was: (i) less salt in bread, US$151; (ii) mass media campaign, US$547; (iii) 
combination drug therapy provided to subjects with a 20%, 10% and 5% global CVD risk, 
US$3,599, US$4,113 and US$4,533, respectively; (iv) high blood pressure lowering 
therapy, US$7,716; (v) tobacco cessation with bupropion, US$33,563; and (iv) high-
cholesterol–lowering therapy with statins, US$70,994 (172). 
Our finding is also consistent with studies in Ethiopia by other researchers, for example, 
the study conducted by Memirie et al. in a CEA of the effectiveness of 13 maternal and 
neonatal health interventions. Our study for malaria interventions is aligned with the study 
conducted by Hailu et al. (161). For the insecticide-treated net, with an ICER of US$207 
per DALY averted (160). 
Evidence-based deliberative prioritisation  
In Paper III, we documented and presented a detailed account of the Ethiopian EHSP 
revision process. A total of 35 consultative workshops were convened with experts and 
various public representatives. Various stakeholders were involved in defining the revision 
scope, developing a list of candidate health interventions, identifying prioritisation criteria, 
gathering evidence and comparing interventions. Seven prioritisation criteria were 




employed for prioritisation (disease burden, cost effectiveness, equity, FRP, budget impact, 
public acceptability and political acceptability). Finally, a comprehensive list of 
interventions was identified (1,018 interventions), the interventions were categorised into 
priority groups (high, medium and low), the required resources were estimated, the 
interventions were linked with the existing service delivery platform and an appropriate 
payment mechanism was proposed based on the level of priority.  
Using a priority setting process with multiple criteria was one of the fundamental strengths 
in the revision of Ethiopia’s EHSP (Paper III). In contrast, in Zambia, Kenya and the 
Philippines, the EHSP revision included only cost effectiveness and disease burden to 
define essential services. In Liberia, disease burden, availability of interventions and 
feasibility were used. The Malawian EHSP was prioritised by cost effectiveness, equity, 
services and continuum of care. Other countries also applied a broader range of criteria.  
The criteria for selecting the list of health interventions for the Rwandan health benefits 
package included a high impact, safety, effectiveness, feasibility, sustainability and 
potential contribution in reducing the burden of disease. In Botswana, the EHSP was 
selected by considering the burden of disease, cost effectiveness and equity (urban/rural, 
pro-poor) while in Chile the prioritisation criteria were burden of disease, share of the 
population suffering from the disease, expected cost per beneficiary, supply capacity of the 
health system and the effectiveness of interventions. Cost effectiveness, affordability, FRP, 
scientific community opinion and cost effectiveness and budget impact were used as 
prioritisation criteria in Mexico and Iraq to formulate their EHSPs. In contrast, Bangladesh 
used the burden of disease, cost effectiveness and FRP as criteria (131-146). 
Open and participatory process 
Another essential feature of the Ethiopian EHSP is that an open and participatory process 
involving internal and external stakeholders was employed. Stakeholders from the health 
sector, through associations and public representatives, were invited and involved. This is 
similar to the Liberian and Malawian EHSP-defining processes in which open, participatory 
processes were employed involving people from local communities, districts and national 




and international organisations in determining priority services. A consultative process was 
held with stakeholders to consider a more comprehensive political and ethical approach for 
the health system. Rwanda’s MOH also led the country’s process for defining the EHSP in 
collaboration with the health insurance agency and in consultation with the government 
cabinet. The result was published in an official MOH gazette available to the public and 
critical stakeholders. In contrast, the Philippines and Iraq revision processes were based 
mainly on data and quantitative exercises (132-134, 138). 
5.2 Lessons learned from the Ethiopian EHSP revision 
In principle, priority setting for designing a health benefits package should employ 
evidence-based, open, deliberative, participatory decision-making processes (11, 24, 66).. 
In practice, however, setting priorities in health service delivery is a challenging and 
complex exercise. In this regard, the revision of the Ethiopian EHSP was a systematic 
exercise to apply those critical principles within various technical and financial constraints. 
This process can be used as a practical example for other LMICs or for future revision in 
Ethiopia. Comparing the approach that we applied in the Ethiopian EHSP revision process 
vis-à-vis normative recommendations, I draw eight lessons for similar future work in 
Ethiopia or other LMICs. 
Political commitment 
Involving policymakers from all levels from the beginning is essential (24). There was 
exemplary political commitment and country ownership in Ethiopia that drove the revision 
of the EHSP. It was well embedded in the existing governance system and structure of the 
MOH. The MOH leadership from the top level to the medium and low levels were actively 
engaged.  
Road map for the revision 
The preparation of the road map for the revision of the EHSP was the most crucial step as 
it shaped the whole process (24). Starting by preparing the road map for the revision makes 
the process more transparent and robust. The road map included the scope, the objective 




and expected outcomes, methodological details, a timeline, a governance structure, a 
communication plan and the roles and responsibilities of various stakeholders. All 
outstanding technical issues should be predefined in the methodology stage, such as how 
priority-setting criteria should be defined. How should relevant health interventions be 
identified? What approaches to evidence synthesis should be used?  
Timeliness  
The timeliness of the revision is an essential factor for the uptake of the EHSP. An EHSP 
should be prepared ahead of the national strategic plan (e.g., the HSTP in Ethiopia) to 
inform medium- or long-term plans (24). The revision of the Ethiopian EHSP was aligned 
with the national health sector transformation plan. A clear understanding of the time 
needed for the revision is fundamental. For example, the initial timeline proposed in the 
road map for the Ethiopian revision was six months. However, the whole process took about 
18 months (i.e., from May 2018 to November 2019).  
Open deliberation 
An open deliberation process with stakeholder involvement is essential. In this process, we 
learned the essential lesson that robust deliberation with stakeholders is vital to the 
quantitative, data-driven analytic approach (24). However, a clear stakeholder engagement 
plan should govern who is invited to each deliberation process. What role can they play? 
Who makes the final decision? Also, all stakeholders should declare a conflict of interest 
before engaging in any dialogue as commercial interest can be challenging to a fair priority-
setting process (173). 
In Ethiopia, more than 35 workshops were held with various stakeholders. Two rounds of 
dialogue were conducted with external stakeholders, including public representatives, 
professional unions and disease-specific patient organisations. The first meeting discussed 
the prioritisation criteria and the second discussed the selection of interventions, the 
proposed payment mechanism, the service delivery platforms and the final validation of the 




prioritised EHSP. Consultation directly with the public at the grassroots level remained 
limited, however.  
Local values 
Prioritisation criteria should be defined based on country context rather than by using 
generic criteria. Every country decides on national policy goals and the criteria for defining 
its essential health services (24). A legitimate, fair decision-making process begins with a 
transparent and inclusive identification of local values. All appropriate stakeholders should 
be included in the criteria-selection process. Policy goals and core values in many settings 
include health promotion and health improvement, equitable access to services, fair 
distribution of health outcomes, quality and FRP. Non-discrimination and solidarity are 
other core values.  
Social values play an essential role in the selection of benefits. Social and political 
acceptability is also essential but must respect norms against legal or de facto discrimination 
against any given population or stakeholder group. 
Comprehensive package 
The Ethiopian EHSP was defined comprehensively. Some countries have defined the 
essential packages for PHC and tertiary health care separately. Some countries have 
separated the NCD and RMNCH packages. However, having a single comprehensive 
package that encompasses all levels of care and all types of disease/health condition is vital 
for various reasons, such as allocating the available resources for the health sector (174). 
Therefore, we recommend that other countries aim and work towards a more 
comprehensive package.  
Linking with a financing mechanism  
Estimating the required resources for implementing an EHSP is vital to examining its 
feasibility and affordability (11, 24). In this study, we estimated the financial resources 
required to implement the Ethiopian EHSP from 2020–2030, and we explored potential 
alternatives to increase the fiscal space for health in Ethiopia. Furthermore, in a sensitivity 




analysis, we examined the possible impact of the Covid-19 pandemic on both the resources-
needed and resources-available sides. 
Linking with monitoring and evaluation  
Linking with an implantation, monitoring and evaluation system and the ‘Theory of 
Change’ is necessary to enable taking corrective action during implementation and to 
document the lessons learnt in implementation (11, 24). The EHSP was launched in 
November 2019, and it has been active for about a year. The revised EHSP has been used 
in HSTP II, HRH, the optimisation of the health extension program (HEP) and in the 
primary care planning process.  
Maintaining EHSP implementation during the Covid-19 pandemic 
Like many other countries, Ethiopia has been substantially impacted by the Covid-19 
pandemic. The Covid-19 pandemic impacts the delivery of essential health services by 
hindering the health system’s capacity (175). In response to this, the MOH adjusted its 
strategy to include the continuity of essential health services as a vital component of the 
Covid-19 response. The ministry prepared an implementation guide that addresses how 
non–Covid-19 essential health services in Ethiopia can be delivered during the Covid-19 
pandemic (176). The revised EHSP was used as a guiding document for prioritising priority 
health interventions in the context of Covid-19 (175). This guideline outlines the steps 
health facilities at all levels must take to ensure that the full range of essential health 
services continues, including safety protocols to prevent Covid-19 transmission. The MOH 
has continued to closely monitor the population’s use of essential health services weekly, 
and, from March 2020, produced monthly monitoring reports with detailed data on trends 
in the utilisation of a range of maternal health, child health and communicable and NCD 
interventions. The results of these efforts have been promising.  
5.3 Methodological discussion  
Despite all efforts made to ensure reliability and rigour of the studies in this thesis, our 
analysis is liable to some limitations that affect the findings’ internal and external validity. 




Some of the limitations are specific to individual studies included in this thesis while some 
are generic to the overall priority-setting approach or economic evaluation method for 
defining the EHSP in Ethiopia. Therefore, in this part of the discussion, I critically examine 
the designs, the sampling and selection of indicators and the data collection and analytical 
techniques of the studies included in this thesis. Throughout, I evaluate the potential 
implications on validity, reliability and generalisability (32, 177-179).  
5.3.1 Study designs  
The choice of study design depends not only on the nature of the research questions under 
investigation but also on other practical issues (e.g., the urgency of the evidence needed, 
ethical issues, data availability, feasibility) (32, 177, 180). In Paper I, of the three prominent 
alternative approaches for measuring UHC service coverage status (86-88), we employed 
the framework proposed by WHO. This approach requires a retrospective review of service 
coverage information from various secondary sources (86). The main limitation of this 
approach compared with the approach proposed by the IHME is that it measures only UHC 
contact coverage (i.e., the quality of the service was not accounted for). Our approach used 
only 16 tracer indicators on RMNCH, NCD, ID, and service availability and access in 
measuring the UHC index while other essential areas such as mental health, NTDs and 
injury were not incorporated. Therefore, further methodological research is needed to refine 
the UHC service coverage index measurement tool. However, both the approach we 
employed and the IHME approach rely heavily on retrospective data. Based on global 
comparability and data availability, we used the WHO/WB approach, which is very 
relevant for policymakers.  
In Paper II, we employed a GCEA approach to generate ACERs for 159 health intervention. 
The alternative economic evaluation approach was to use an incremental CEA. In general, 
criticism has been growing against CEA in priority-settings decisions (181). Also, 
methodological discrepancies across comprehensive economic evaluations and the 
inadequate generalisability and transferability of results to circumstances beyond the 
original study setting are challenges in the sector-wide analysis (182-184).  




In Paper III, we employed a combination of designs. For example, more participatory 
observational methods were used to document and synthesise the revision process. Costing 
and fiscal space analysis approaches were used to estimate the resource need, predict 
expected available resources and estimate the affordability of the EHSP. To measure the 
equity and FRP implications of the interventions, the Delphi technique was used. These 
diverse methods may not capture all the relevant information, which may have affected the 
various health interventions’ rankings. For example, data from the Delphi process may lack 
validity since it depends on expert judgement of few individuals, data from secondary 
sources might be outdated and may not be regularly updated, and cost data from small 
studies may not represent the situation in whole country (182-184). Much more work is 
therefore needed to develop these methods further.  
5.3.2 Data availability and quality 
Both the availability and the quality of data were crucial limitations for all three papers in 
this thesis: for the estimation of UHC service coverage, for the CEA and in defining the 
EHSP. In Paper I, various data sources were used, including the HMIS, the 2016 EDHS 
(113), the 2015 MIS (158) and the NCD STEPS survey (157). Additionally, inpatient 
admissions per capita, human resource distribution and health security information was 
collected from administrative records at the MOH and regional health offices. SARA data 
were also used for measuring access to essential medicines.  
Data routinely collected for other purposes have various limitations. For example, as most 
of the secondary sources’ information was not disaggregated by gender, socioeconomic 
status or other relevant parameters, we could not show the inequalities in the coverage 
across socioeconomic groups. Data on International Health Regulations (IHR) were not 
available from any source, and primary rapid assessment was conducted using expert 
judgement (interviews). Expert judgement is prone to bias.  
In Paper II, various data sources from the MOH were used for estimating the interventions’ 
effectiveness. The measurement of health benefits was also, to some extent, based on a 




regional or international estimate of the impact of the interventions. The impact 
(effectiveness) of an intervention may be different in actual implementation in Ethiopia.  
In Paper II, estimating the financial and economic cost of interventions was challenging 
because of the lack of primary sources of cost data at the country level for most inputs. We 
therefore modified the OHT data using different local or international data sources, such as 
HRH, EPSA and an international drug price database (MSH). Using data of diverse quality 
might affect the results.  
5.3.3 Other limitations  
Another limitation in the revision of the EHSP in Ethiopia may be the composition of the 
team conducting evaluation, appraisal and decision. Some researchers recommend that 
separate teams should conduct these activities. Similarly, in addition to my research role as 
a PhD candidate, I was co-leading the revision of the EHSP and heavily involved in the 
process. Therefore, Paper III, which aimed to synthesise and document the process, 
methods and critical features of the revised EHSP, may suffer somewhat from ‘researcher 
bias’ and should not be taken as a full evaluation study (185). Results should be interpreted 
with caution. Hence, it is essential that independent researchers further evaluate the revision 
process to assess the process and draw more lessons from it.  
To mitigate the researcher’s effect on the final result, however, we ensured that a technical 
working group was instituted early on and that this group would review the core team’s 
work independently. Second, the process also involved diverse national and international 
experts for quality assurance, and the preliminary results of each activity were presented 
and debated externally before any decision was made.  
  




Chapter 6. Conclusion and Recommendations 
6.1 Conclusions  
In this thesis, based on the findings of the first study, we conclude that the Ethiopian 2015 
overall UHC service coverage was low compared with most other countries in the region. 
Furthermore, there was substantial variation in coverage between regions and across health 
service programmes.  
Based on paper II, we conclude that the WHO-GCEA tool can be used to calculate country-
specific CEA values for many health interventions under consideration for Ethiopia’s 
EHSP, and several potentially cost-effective interventions are available that could 
substantially reduce Ethiopia’s disease burden if scaled up. 
Based on the third study, the Ethiopian EHSP has defined a set of affordable promotive, 
preventive, curative and rehabilitative priority health interventions that will be provided at 
all levels of service delivery in an equitable, acceptable and sustainable manner on the path 
towards UHC. In defining the Ethiopian EHSP, disease burden, cost effectiveness, equity, 
FRP, budget impact, public acceptability and political acceptability criteria were used. To 
compare and rank the interventions, the best available quantitative and qualitative evidence 
was employed. In the EHSP revision process, several rounds of consultations were held 
with public representatives, professional associations and subject-matter experts. 
The revised Ethiopian EHSP includes 1,018 interventions organised into nine major 
programme areas and represents the most comprehensive revision process undertaken in a 
sub-Saharan African country. Having a detailed and comprehensive intervention list can 
help to ensure that essential interventions from all programme areas are included as part of 
UHC. 
Furthermore, multi-criteria decision-analysis (MCDA) using the best available evidence 
(data), broad consultation with all stakeholders (dialogue) and an open, transparent and 




democratic decision-making process (decision) are vital in defining an EHSP at the national 
level.  
6.2 Recommendations and future perspectives 
• To reach the UHC service coverage target, Ethiopia should rapidly scale up promotive, 
preventive and curative health services. Also, policymakers at the regional and federal 
levels should take corrective measures to narrow the gap in UHC service coverage 
between regions by redistributing the health workforce, increasing resource allocation 
to health and providing focused technical and financial support to low-performing 
regions.  
• To strengthen and deepen its effort on UHC, the MOH needs to intensify its work in 
increasing the production and motivation of a high-quality health workforce.  
• EHSP implementation at both the federal and regional levels should be strengthened. 
Linking priority interventions with existing service delivery, financing and payment 
mechanisms can help facilitate implementation.  
• These measures require new and better financing mechanisms; therefore, wholistic 
health care financing reform should be undertaken to improve available resources for 
health in Ethiopia. 
• More economic evaluation studies, especially on NCDs and multi-sectoral 
interventions, should be conducted to generate more evidence for priority setting. 
• The foundation for the establishment of the HTA platform in Ethiopia should be started 
as soon as possible, including establishing a legal framework,  
• Future priority-setting research should focus on designing advanced equity and FRP 
analysis and integrating these concerns with traditional CEA.  
• Capacity building for the MOH staff on health economics and financing is essential.  
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Key questions
What is already known?
 ► Measurement of service coverage is important for 
monitoring progress towards universal health cov-
erage (UHC).
 ► The WHO and the World Bank has made country es-
timates of UHC service coverage, including Ethiopia.
What are the new findings?
 ► This paper estimates UHC service coverage for 
Ethiopia for the year 2015.
 ► The estimated subnational UHC service coverage 
varies substantially across regions and programme 
areas.
What do the new findings imply?
 ► Ethiopia should make an extra effort to achieve UHC 
service coverage goals in the next decade.
 ► Policymakers in Ethiopia should be cognisant of the 
subnational variation in UHC service coverage and 
should take corrective measures to narrow the gap 
across regions.
AbsTrACT
Introduction Aiming for universal health coverage (UHC) 
as a country- level goal requires that progress is measured 
and tracked over time. However, few national and 
subnational studies monitor UHC in low- income countries 
and there is none for Ethiopia. This study aimed to estimate 
the 2015 national and subnational UHC service coverage 
status for Ethiopia.
Methods The UHC service coverage index was 
constructed from the geometric means of component 
indicators: first, within each of four major categories and 
then across all components to obtain the final summary 
index. Also, we estimated the subnational level UHC service 
coverage. We used a variety of surveys data and routinely 
collected administrative data.
results Nationally, the overall Ethiopian UHC service 
coverage for the year 2015 was 34.3%, ranging from 
52.2% in the Addis Ababa city administration to 10% 
in the Afar region. The coverage for non- communicable 
diseases, reproductive, maternal, neonatal and child health 
and infectious diseases were 35%, 37.5% and 52.8%, 
respectively. The national UHC service capacity and access 
coverage was only 20% with large variations across 
regions, ranging from 3.7% in the Somali region to 41.1% 
in the Harari region.
Conclusion The 2015 overall UHC service coverage 
for Ethiopia was low compared with most of the other 
countries in the region. Also, there was a substantial 
variation among regions. Therefore, Ethiopia should rapidly 
scale up promotive, preventive and curative health services 
through increasing investment in primary healthcare if 
Ethiopia aims to reach the UHC service coverage goals. 
Also, policymakers at the regional and federal levels 
should take corrective measures to narrow the gap across 
regions, such as redistribution of the health workforce, 
increase resources allocated to health and provide focused 
technical and financial support to low- performing regions.
InTroduCTIon
Universal health coverage (UHC) is realised 
when everyone has access to quality essential 
healthcare services with financial risk protec-
tion.1 The United Nations General Assembly, 
as part of the Sustainable Development Goal 
for health, calls on all countries to ensure 
UHC by 2030.2 Health services that should be 
provided include essential promotive, preven-
tive, curative, rehabilitative and palliative 
health services.1 However, each year, almost 
half of the world’s population cannot access 
needed health services and about 100 million 
people are forced into extreme poverty 
because of health expenses. Globally, about 
800 million people experience catastrophic 
financial hardship due to out- of- pocket 
healthcare spending (ie, spending more than 
10% of their total income for healthcare).3
Ethiopia is one of the countries with a 
substantial disease burden from reproduc-
tive, maternal, neonatal and childhealth 
(RMNCH) and infectious diseases.4 Recent 
evidence also shows that the magnitude 
of non- communicable disease (NCD) and 
injuries is rising in Ethiopia.5 In addition, 
coverage of both basic health services and 
health service utilisation is low, and there 
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is a high geographical (urban- rural area and regional/
subnational) inequality in service coverage.6 Further-
more, catastrophic out- of- pocket spending is high.7
Cognisant of these challenges, the government of Ethi-
opia has developed key strategies to lead to UHC. These 
strategies include the following: first, defining the Essen-
tial Health Service Package of the country and identifying 
prioritised health interventions; second, exemption or 
cost- sharing of high- priority interventions; third, expan-
sion of community- based health insurance programmes; 
fourth, integration of health services within other sectors 
from the national to the district level to address social 
determinants of health and fifth, establish emergency 
preparedness and response units at the level of both the 
national and Regional Health Bureaus (RHBs). Taken 
together, these strategies can improve the coverage of 
essential health services, reduce inequalities and provide 
financial risk protection.8 9
Despite a promise to provide all needed service to the 
whole population, UHC must be realised progressively, 
especially in resource- constrained countries. Respon-
sibilities in the provision of UHC need to be redefined 
to a comprehensive set of essential health services that 
the government can guarantee to the entire popula-
tion.10 Therefore, with UHC as a global and country- level 
health policy goal, the need to measure and track its 
progress over time is imperative. WHO and World Bank 
(WB) have jointly identified two indicators for moni-
toring progress towards UHC: essential health service 
coverage (target number 3.8.1) and financial risk protec-
tion (target number 3.8.2). The 2030 UHC- Sustainable 
DevelopmentGoals (SDG) targets are intended to reach 
at least 80% for service coverage and 100% for financial 
risk protection.11
One challenge in the identification of UHC moni-
toring indicators is to decide how comprehensive the 
indicators should be to represent all essential health 
services in the system and control the number of indica-
tors to enable comparability across countries that differ 
in terms of epidemiological and demographic character-
istics. Boerma et al argue that country- level monitoring 
of UHC should address the epidemiological and demo-
graphic peculiarities in the country, while the inter- 
country comparison is more important for monitoring 
and comparing progress towards UHC.12
Hogan et al have proposed a metric for the monitoring 
of UHC: in particular, target 3.8.1. This seminal paper 
constructs a composite indicator to estimate UHC in a 
single number.3 The indicator comprises four elements: 
reproductive, maternal, new- born and child health; infec-
tious diseases; NCDs and service capacity and access. The 
authors argue that the application of this single indicator 
can be used to compare the progress of different coun-
tries and monitor a country’s progress towards UHC.3
Although Wagstaff and colleagues were able to demon-
strate the feasibility of an index- based approach to 
measuring, monitoring and comparing progress towards 
UHC,13 only a few empirical studies attempt to estimate 
UHC status at the country level. Barasa, Nguhiu and McIn-
tyre use Demographic and Health Survey (DHS) data to 
estimate Kenya’s UHC progress using tracer indicators 
grouped as preventive and treatment interventions.14 In 
Ethiopia, a case study regarding the identification of a 
UHC monitoring tool recommends that the UHC tracer 
indicators should be comprehensive, few in number and 
focused on impact, outcome and health systems dimen-
sion indicators. The case study also supports the inclu-
sion of indicators that can capture NCDs.15 Except for 
Hogan et al,3 we have not found other empirical studies 
estimating the UHC status for Ethiopia, and none have 
attempted to demonstrate subnational variations in 
universal service coverage. In addition, the Ministry of 
Health does not use an explicitly defined UHC moni-
toring framework. Therefore, this study aimed to esti-
mate the 2015 national and subnational UHC status for 
Ethiopia, which could serve as a baseline to monitor Ethi-
opia’s progress towards UHC.
MeTHods
The ethiopian health system
Ethiopia is the second most populous country in Africa, 
with a total population of about 105 million in 2016.16 
Administratively, Ethiopia is divided into nine regional 
states (Tigray, Afar, Amhara, Oromia, BenshangulGu-
muze, Southern Nations, and National Region (SNNPR), 
Somali and Harari) and two chartered cities (Addis 
Ababa and Dire Dawa).
Healthcare delivery in Ethiopia is organised in a three- 
tier system.8 The first, at the district level, is the primary 
healthcare unit (PHCU). The PHCU comprises one 
primary hospital, which can serve a population of about 
60 000–100 000; four health centres (each serving a 
population of 15 000–25 000) and five health posts are 
attached to each health centre (each health post serving 
3000–5000 people). The second level comprises general 
hospitals, each serving a population of 1–1.5 million, 
while the third level comprises specialised hospitals for a 
population of 3.5–5 million.
While the Federal Ministry of Health is respon-
sible for the formulation and harmonisation of health 
programmes and strategies, the RHBs are mostly respon-
sible for actual implementations. The budget flows to 
RHBs in two ways. From one side, the RHBs receive about 
5%–10% of the total annual regional budget. This part of 
the budget is mainly spent on salaries for health profes-
sionals, procurement of medical supplies and procure-
ment of drugs. The regions also use this part of the 
budget for construction and expansion of health centres 
and primary hospitals. The RHBs have a full mandate on 
this part of the budget. On the other side, RHBs receive 
an additional earmarked budget for specific programmes 
from external sources via the Federal Ministry of Health. 
In addition, the Ministry of Health also distributes un- ear-
marked funds from the SDG pool fund.
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Table 1 Sources of data and indicator description for the UHC service coverage tracer indicators
Major indicators Tracer indicator Description Data source
RMNCH Family planning Demand satisfied with modern methods among women 15–49 
who are married or in a union
EDHS
Pregnancy care Average coverage of 4 or more antenatal visits and skilled birth 
attendants
EDHS
Full child immunisation One- year- old children who have received 3 doses of vaccine 
containing diphtheria, tetanus and pertussis
EDHS
Child treatment Care- seeking behaviour for children with suspected 
pneumonia
EDHS
Infectious diseases Tuberculosis treatment TB cases detected and cured WHO
HIV treatment People living with HIV and receiving antiretrovirals (ART) HMIS
Malaria prevention The population at risk sleeping under insecticide- treated bed 
nets
MIS
Improved water and 
sanitation
Average coverage of households with access to improved 
water and sanitation
EDHS
NCDs Prevention of CVD Prevalence of no raised blood pressure STEPS
Management of DM Prevalence of no raised blood glucose STEPS
Cervical cancer 
screening
Cervical cancer screening among women 30–49 STEPS
Tobacco control Adults age ≥15 years not smoking tobacco in the last 30 days STEPS
Service capacity and 
access
Hospital access In- patient admissions per capita HMIS
Health worker density Health professionals per capita physicians, psychiatrists and 
surgeons
HRIS
Access to essential 
medicines
The average proportion of the WHO- recommended core list of 
essential medicines present in health facilities
SARA
Health security International Health Regulations core capacity index Primary
CVD, cardiovascular disease; DM, diabetes mellitus; EDHS, Ethiopia’s Demographic and Health Survey; HMIS, Health Management 
Information System; HRIS, Human Resource Information System; MIS, Malaria Indicator Survey; NCDs, non- communicable diseases; 
RMNCH, reproductive, maternal, neonatal and child health; SARA, Service Readiness and Availability; TB, tuberculosis; UHC, universal 
health coverage.
service coverage indicators
In this study, we applied the approaches described 
by Hogan et al and the WHO/WB report on tracking 
progress towards UHC, with some modifications.3 11 We 
used local data sources and checked that the indicators 
were also relevant for Ethiopia and that the data were 
available for all nine regions and the two city administra-
tions. The selected indicators were well aligned with Ethi-
opia’s priorities, set by the health sector transformation 
plan.8 Sixteen indicators are from four major categories: 
RMNCH, infectious diseases, NCDs and service capacity 
and access. Tracer indicators in the area of RMNCH 
were as follows: family planning (FP) demand satisfied 
with a modern method among married women or in a 
union; pregnancy care (PC); immunisation for infants 
with three doses of pentavalent vaccine and care- seeking 
for children with suspected pneumonia. For infectious 
diseases, tracer indicators were tuberculosis treatment 
coverage (TB cases detected and cured); HIV treatment 
coverage; use of insecticide- treated bed nets among 
populations at risk of malaria and household access to 
at least basic sanitation services. For NCDs, we used the 
following: prevalence of non- raised blood pressure (BP), 
mean fasting plasma glucose, cervical cancer screening 
and prevalence of tobacco non- smoking. To assess service 
capacity and access, we used hospital bed density, health 
worker density, access to essential medicines and the 
International Health Regulations core capacity index.
data sources
We used a variety of data sources from Ethiopia (table 1), 
namely Ethiopia’s Health Management Information 
System (HMIS),17 Ethiopia’s 2016 DHS (EDHS),18 the 
2015 Malaria Indicator Survey (MIS),19 the NCD STEP-
wise approach to noncommunicable disease risk factor 
surveillance (STEPS) survey,20 the 2016 Service Readiness 
and Availability (SARA) survey21 and a Human Resource 
Information System (HRIS). Also, health security (HS) 
information was collected from administrative records 
at the Federal Ministry of Health and regional health 
offices. Since this indicator is only available at national 
level only, it is excluded from subnational analysis.
The Ethiopian 2016 DHS data were used to estimate 
UHC service coverage for RMNCH indicators. For 
 on N
ovem









ealth: first published as 10.1136/bm






4 Eregata GT, et al. BMJ Global Health 2019;4:e001843. doi:10.1136/bmjgh-2019-001843
BMJ Global Health
measurement of the malaria prevention indicator, the 
2015 Ethiopian MIS survey was used. The 2016 SARA 
survey was used to estimate the coverage of essential 
medicine. The SARA survey generates a set of core indi-
cators on key inputs and outputs of the health scheme, 
which can be applied to assess progress in the health 
system, strengthening over time.22 To estimate service 
coverage for the prevention of cardiovascular disease 
(CVD), management of diabetes mellitus (DM), cervical 
cancer screening and tobacco control, the NCD STEPS 
survey was applied. The Ethiopia STEPS are a nationally 
representative survey to gather comprehensive data on 
risk factors for NCDs, injuries and violence in Ethiopia. 
To estimate HIV treatment coverage, HMIS data, which is 
routinely collected from service provision at each facility, 
was used. The data source for health workforce (HWF) 
density are the HRIS of the Ministry of Health.
data analysis
estimation of the uHC service coverage index
The UHC coverage index was constructed from geometric 
means of the four major component indicators.3 For the 
RMNCH category, the geometric mean of FP, PC, immu-
nisation and child healthcare (CHC) were taken; for FP, 
contraceptive prevalence rate; for PC, a combination of 
prevalence of births attended by a skill birth attendant 
and prevalence of antenatal care coverage (ANC4+); for 
immunisation, DPT3 coverage and for CHC, treatment 




FP ∗ PC ∗DPT3 ∗ CHC
)1/4
 
For measurement of UHC service coverage in the infec-
tious disease category, tuberculosis treatment (TB) was 
measured using the TB case detection rate and cure rate; 
antiretroviral treatment (ART) coverage was measured 
using people living with HIV who are currently on ART; 
water and sanitation (WASH) was measured using the 
average coverage of households with access to improved 
water and sanitation and Long- lasting insecticidal nets 
(LLIN) coverage was used.
Infectious = ( TB ∗ ART ∗ WASH ∗ ITN right)1/4 
LLIN coverage was not accounted for in Addis Ababa 
since the area is malaria- free.
NCD service coverage was calculated by a geometric 
mean of non- raised BP, fasting blood plasma glucose 
level (FPG), cervical cancer screening coverage and prev-
alence of non- tobacco users. We used the 2015 STEPS 
survey to compute the four tracer indicators in this cate-
gory. The non- raised BP rate was measured by a preva-
lence of systolic BP<140 mm Hg or diastolic BP<90 mm 
Hg among adults aged 18 years and older. The FPG rate 
was measured by a prevalence of fasting plasma glucose 
of ≥7.0 mmol/L or those on medication for raised blood 
glucose among adults aged 18 years or older. The cervical 
cancer screening rate was measured by a proportion of 
women aged 30–49 years who reported ever having had 
a screening test for cervical cancer using any of the 
methods (visual inspection with aceticaccede, pap smear 
and human papillomavirus test). For measurement of no 
tobacco use, the proportion of adults 15 years and older 
who have not smoked tobacco in the last 30 days of survey 
time was applied:
 
NCD = (BP ∗ FPG ∗ Cancer Screening ∗ Tobacco right)1/4
 
We used the prevalence of non- raised BP to estimate 
the service coverage for ‘prevention of CVD’ and the 
prevalence of non- raised blood glucose to estimate the 
service coverage for ‘management of DM’. Since these 
two indicators are not measured in a proportion, we used 
the rescaling formulas recommended by WHO/WB:3
 ► Rescaled value for non- raised BP = (x – 50)/(100 – 
50)*100, where x is the non- raised BP.
 ► Rescaled value for the management of non- FPG 
= (7.1 – y) / (7.1 – 5.1) *100, where y is the mean 
fasting plasma glucose.
For measurement of health service capacity and access 
(HSCA) coverage, hospital access (HP), HWF density, 
HS and data on the availability of essential medicine 
were used. For hospital access, we used annual in- patient 
admission or discharge per capita. For HWF density, we 
used the availability of health professionals: physicians, 
psychiatrists and surgeons per capita. For HS, we used 
the International Health Regulation core capacity index. 
Since this indicator is only available at the national level, 
it was excluded from the subnational analysis. For the 
measurement of essential medicines, we calculated the 
availability of the 14 WHO- recommended core list of 
essential medicines (ie, glibenclamide, beta- blocker, ACE 
inhibitor, simvastatin, amitriptyline, ciprofloxacin, co- tri-
moxazole, amoxicillin, ceftriaxone injection, diazepam 
tablet, diclofenac/ibuprofen, paracetamol and omepra-
zole) at health facilities:
 
HSCA = (Hospital access ∗ HWF ∗ Essential medicines
HS right)1/4
 
Therefore, the overall UHC service coverage was 
computed within each of the four categories and then 
across those category- specific means to obtain the final 
summary index.3
 
UEHSC = (RMNCH ∗ Infectious ∗ NCD
Health Service Capacity right)1/4
 
We computed the regional- level UHC service coverage 
status in the same way as the national index and compared 
their distributions to the national coverage and among 
regions. In this analysis, the geometric mean was applied 
instead of the arithmetic mean because the geometric 
mean is less sensitive to extreme values.19
We tested the sensitivity of the index to see how the 
indicators were combined into a summary measure by 
recomputing the index, using the arithmetic means in 
addition to the geometric means that was performed in 
the base case. We also assessed the sensitivity of the index 
by dropping one indicator at a time: first, deleting the HS 
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variable and then deleting the entire ‘health service and 
capacity’ component.
Patient and public involvement statement
The study was approved by the Institutional Review 
Board (IRB) of the Ethiopian Public Health Institute 
(Ref: EPHI/6.13/607). No patient level data were used 
in this study.
resulTs
The Ethiopian overall UHC service coverage for the year 
2015 was about 34.3% (table 2), ranging from 52.2% in 
Addis Ababa to 10% in Afar region (figure 1).
We also explored UHC service coverage variation 
across areas of service indicators (figure 2). The national 
RMNCH service coverage was 37.5%; in this category, PC 
(29.8%) was the lowest performing area, as traced by FP 
(35%) and child treatment (35.3%). However, immu-
nisation coverage was relatively higher (53.2%) in this 
category.
The national UHC service coverage for the infectious 
disease category was 52.8%. In this category, the lowest 
coverage was for LLIN (39.7%), followed by HIV treat-
ment (55%) and TB treatment (59.6%). The highest 
coverage in this category was for improved water and 
sanitation (59.9%).
The national UHC for the NCD category was 35%, 
while the national UHC service capacity and access 
coverage was only 20%, with the highest variation across 
regions ranging from 3.7% in Somali to 41.1% in Harari 
(figure 3).
The UHC index was very sensitive to the choice of 
summary method. If we had chosen to use the arithmetic 
mean instead of the geometric mean, the UHC index 
would be 47.7%. Similarly, the index is sensitive to the 
type of indicators selected. Deleting the ‘health service 
and capacity’ component resulted in a UHC index of 
41.1%, while deleting the HS variable would have resulted 
in a UHC index of 30.3%.
dIsCussIon
In this study, we attempted to estimate UHC service 
coverage for Ethiopia using 16 tracer indicators classi-
fied into four major groups: RMNCH, infectious disease, 
NCD and service access and capacity. We identified low 
UHC service coverage, substantial regional variations 
and a difference in achievement across programme 
areas. These findings trigger two key policy- relevant ques-
tions: Will Ethiopia achieve the UHC- SDG target, given 
the current level? How can we narrow the subnational 
variations and the large differences by programme areas?
low uHC service coverage
In this study, we identified that the 2015 overall UHC 
service coverage for Ethiopia (34.3%) was very low. This 
coverage level is substantially behind the SDG target of 
80% by the year 2030 and also much lower compared with 
most Eastern African countries.2 For instance, the 2015 
WHO/WB UHC service coverage estimate for Eastern 
African countries ranged from 39% in Tanzania to 57% in 
Kenya. A similar study by Barasa et al found a UHC service 
coverage for Kenya of about 42% in 2013.14 The coverage 
for Ethiopia is also considerably lower compared with the 
global average service coverage (64%) and sub- Saharan 
Africa average (42%).3
This low service coverage can be partially explained 
by demand- side factors, such as high multidimensional 
poverty among a large majority of the Ethiopian house-
holds.23 24 In Ethiopia, more than one- fourth of the entire 
population lives under the absolute poverty- line.25 26 
Also, the low literacy rate, together with poor modern 
healthcare- seeking behaviour, could contribute to low 
coverage.27 From the supply side, minimal investment 
in Ethiopian health services could be the main reason 
for low UHC service coverage. For instance, although 
WHO recommends investing about US$112 per person 
annually (for low- income countries) to achieve the UHC- 
SDG target,28 Ethiopia was only investing about US$28 
per capita.29 Therefore, it is reasonable to assume that 
the health infrastructure and human resources for health 
could have been better in Ethiopia if adequate resources 
had been mobilised in the health sector. However, 
achieving UHC requires the mobilisation of resources 
and equitable, transparent and efficient allocation and 
use of resources.30
Furthermore, our estimate (34.3%) is lower than 
an estimate by Hogan et al. (39%) and the WHO/WB 
report on tracking progress towards UHC for Ethi-
opia.3 11 This can be explained by the difference in the 
number of tracer indicators included and data sources 
applied in the studies. While our study includes all 16 
recommended tracer indicators from more reliable data 
sources, Hogan et al used only 14 of the tracer- indictors 
(ie, excluding cervical cancer screening and access to 
essential medicine).
Variation in achievement across programme area
As presented in detail in the WHO/WB joint technical 
report, the selection of the 16 tracer indicators is based 
on the definition of SDG 3.8.1, and all indicators are 
included with the intent to represent a given section of 
the health system.11 Countries should show progress in all 
areas of the tracer indicators to achieve UHC. Therefore, 
the comparison of tracer indicators across programme 
areas is important in identifying the gaps. Our study 
demonstrates immense variation in service coverage 
across different components of the UHC progress indica-
tors. The national coverage for infectious disease (52.8%) 
is higher than RMNCH (37.5%) and NCDs (35%). The 
service capacity and access coverage (20%) was the 
lowest. The difference between higher coverage for 
infectious disease and service capacity and access might 
somehow reflect disease- oriented ‘priorities of the health 
system’ in previous years in Ethiopia as well as globally.31 
This discrepancy was also reflected in the healthcare 
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Figure 1 Overall UHC service coverage across regions. 
AA, Addis Ababa; BG, Benshangul Gumuze; DD, Dire Dawa; 
SNNPR, Southern Nations, and National Region; UHC, 
universal health coverage.
Figure 2 UHC service coverage across area of service 
indicators. NCD, non- communicable diseases; RMNCH, 
reproductive, maternal, neonatal and child health; UHC, 
universal health coverage.
Figure 3 Regional variation of UHC SC tracer indicators. 
AA, Addis Ababa; BG, Benshangul Gumuze; DD, Dire Dawa; 
NCD, non- communicable diseases; RMNCH, reproductive, 
maternal, neonatal and child health; SNNPR, Southern 
Nations, and National Region; UHC, universal health 
coverage.
financing landscape that the larger share of the health 
resource in Ethiopia had been spent on major infectious 
diseases (ie, HIV, TB and malaria), followed by RMNCH 
services. The discrepancy can be partly ascribed to the 
influence of ‘donor- driven prioritisation’. For example, 
cervical cancer screening coverage is very low (about 
3%). Therefore, the reprioritisation of health services—
based on local disease burden data—in a way that can 
provide equitable and sustainable service provision may 
be an important consideration for the Ministry of Health 
to improve the gap across the UHC programme area and 
increase the total health gained for a fixed amount of the 
available budget.32
In terms of service capacity and access, most of the 
UHC coverage indices are low. Access to essential medi-
cine was 50.8%, and only 13% of the population had 
access to hospital admission service. Alarmingly, we 
identified that there is a very low health worker density 
(3.1%). Since Ethiopia has invested in low- skilled health 
extension workers at community level (with 1–2 years of 
health education), the human resource profile in Ethi-
opia indicates that there is a shortage in many of the 
highly skilled healthcare provider categories recom-
mended by global standards, and there is a critical 
shortage of surgeons and psychiatrists. For instance, 
there are only about 35 psychiatrists and 190 surgeons 
in the country for a population of 105 million. A study 
in central Ethiopia also reports a similar finding using 
hospital- based data.33 Therefore, the Ethiopian health 
system should clearly define a minimum set of important 
health services that are vital to the Ethiopian popula-
tion and define the necessary workforce and health 
technologies, including essential medicine and phys-
ical infrastructure that matches the size and mix of the 
health needs of the whole population. Furthermore, the 
Ministry of Health should undertake a detailed analysis 
and close monitoring of the HWF density and distribu-
tion for all HWF categories both at national and subna-
tional levels. Most importantly, these minimum inputs 
should be linked with adequate, sustainable financing 
mechanisms to ensure its continuity.
The relatively good coverage of tobacco control 
(89.2%), management of diabetes (100%) and CVD 
treatment (58.2%) can be due to the physically active 
lifestyle of the large majority of the Ethiopian popula-
tion (ie, mostly rural residents and physically vigorous 
working conditions). However, the methodological 
limitations of how the indicators are constructed should 
be taken into account when interpreting these findings. 
In this study, tobacco control was defined as adults age 
≥15 years not smoking tobacco in the last 30 days of the 
surveying period; management of diabetes is defined as 
the prevalence of non- raised blood glucose; and CVD 
treatment is defined as the prevalence of non- raised 
BP. Key components of the indicator are based on risk 
factors also influenced by factors other than service provi-
sion and access. To adjust for this limitation, we included 
coverage of cervical cancer screening. Without this indi-
cator, the mean score for NCDs would have been much 
higher (and incorrect). Therefore, we recommend that 
these tracer indicators be replaced with indicators that 
directly measure the performance of the health system 
(if possible, effective coverage indicators). Similarly, a 
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subnational variation
Our study reveals that there was huge subnational varia-
tion across different areas, ranging from service coverage 
of about 10% in the Afar region to 52.2% in the capital. 
Essentially, the variability in the UHC SC index might 
be partially explained by variations in both supply- side 
factors (ie, availability of health personnel and infrastruc-
ture) and demand- side factors (ie, socioeconomic status 
and literacy rate). The service coverage in the emerging 
regions, such as Afar, Benshangul Gumuze, Somali region 
and Gambla, was far lower than the national average. The 
target stated in the Health Sector Transformation Plan is 
to bring coverage of the emerging regions to the national 
average.8
Therefore, policymakers and programme managers 
in Ethiopia should give more attention to the needs of 
emerging regions. For instance, an intensified, targeted 
and focused intervention can be launched, special 
technical support can be organised and the pastoralist 
programme can be strengthened. In addition, the 
Federal Ministry of Health, together with RHBs of the 
emerging regions, should design a joint strategic plan to 
help bring regions with low UHC coverage to reach the 
national average in a short time. These strategies might 
include allocating additional funds from the national 
treasury for health in emerging regions; training and 
deployment of new highly skilled health professional 
to pastoralist regions that will also need incentives to 
retain such workforces; expansion of health infrastruc-
ture; improvement of procurement and distribution of 
essential drugs, supplies and medical equipment and 
designing region- specific implementation plans that 
take the regional context into account. Regional govern-
ments should also increase the proportion of allocated 
resource to the health- sector from the regional budget.
strength and limitations of the study
This study is the first of its kind in both fully constructing 
the UHC measurement index and measuring UHC 
service coverage at the national and subnational 
(regional) levels. However, the current study has some 
limitations related to either the selection of tracer indi-
cator or the data sources, which require results to be 
interpreted with care. First, the identification of appro-
priate tracer indicators among several measures of 
service indicators is challenging for different reasons. 
In theory, the UHC encompasses several health service 
components. Second, the availability of appropriate 
data was a huge challenge and, therefore, some of the 
tracer indicators were proxy indicators, which only 
demonstrated the extent of the disease burden (eg, the 
prevalence of hypertension and FPG) rather than the 
actual service coverage.
Moreover, the coverage index does not adjust for 
quality. Findings from Service Provision Assessment 
(SPA) and SARA, as well as other studies, indicate that 
the quality of service provision is low and has substantial 
regional variation.34 35 Although data were not available 
to estimate effective coverage, as defined by Ng et al, it 
is not unreasonable to assume the effective coverage 
would be even lower than 34.3%.36
Regarding the data sources, we extensively applied 
survey data rather than routine administrative data. 
However, since survey data were not available to esti-
mate service coverage of ART for HIV/AIDS, routine 
data from the health information management system 
was applied. Similarly, for tuberculosis, data from 
the WHO data repository were used. These routinely 
collected data might have limitation since these data 
were mainly collected by health professionals at health 
posts and health centres who have limited skill and a 
weak data quality monitoring system.37 38
Although wealth quintile data for some of the tracer 
indicators can be established from the survey data, disag-
gregated data by household socioeconomic status was 
lacking for some of the tracer indicators. Thus, we did 
not include inequality analysis across wealth quintiles.
ConClusIon
The overall UHC service coverage for Ethiopia in 2015 
was 34.3%. That outcome is much lower compared with 
other countries in the region and the SDG- UHC target 
by 2030. There are also substantial subnational varia-
tions in coverage indicators and, therefore, an inten-
sified effort is needed to achieve the intended result 
within the next 10 years nationally, especially in the 
regions lagging behind the national average. In addi-
tion, policymakers should be aware of the regional 
variation in UHC service coverage indicators and take 
corrective measures to narrow the gap across regions. 
The Ministry of Health should also start benchmarking 
progress towards UHC at the subnational level. In 
addition, a catch- up plan for regions that are lagging 
should be designed, such as redistribution of the HWF, 
increased resource allocations to health and focused 
technical and financial supports. In sum, Ethiopia 
should scale up its coverage of promotive, preven-
tive and curative health service through increasing its 
investment in primary healthcare.
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of 159 health interventions for the Ethiopian 
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Abstract 
Background: Cost effectiveness was a criterion used to revise Ethiopia’s essential health service package (EHSP) in 
2019. However, there are few cost-effectiveness studies from Ethiopia or directly transferable evidence from other 
low-income countries to inform a comprehensive revision of the Ethiopian EHSP. Therefore, this paper reports average 
cost-effectiveness ratios (ACERs) of 159 health interventions used in the revision of Ethiopia’s EHSP.
Methods: In this study, we estimate ACERs for 77 interventions on reproductive maternal neonatal and child health 
(RMNCH), infectious diseases and water sanitation and hygiene as well as for 82 interventions on non-communicable 
diseases. We used the standardised World Health Organization (WHO) CHOosing Interventions that are cost effective 
methodology (CHOICE) for generalised cost-effectiveness analysis. The health benefits of interventions were deter-
mined using a population state-transition model, which simulates the Ethiopian population, accounting for births, 
deaths and disease epidemiology. Healthy life years (HLYs) gained was employed as a measure of health benefits. We 
estimated the economic costs of interventions from the health system perspective, including programme overhead 
and training costs. We used the Spectrum generalised cost-effectiveness analysis tool for data analysis. We did not 
explicitly apply cost-effectiveness thresholds, but we used US$100 and $1000 as references to summarise and present 
the ACER results.
Results: We found ACERs ranging from less than US$1 per HLY gained (for family planning) to about US$48,000 per 
HLY gained (for treatment of stage 4 colorectal cancer). In general, 75% of the interventions evaluated had ACERs of 
less than US$1000 per HLY gained. The vast majority (95%) of RMNCH and infectious disease interventions had an 
ACER of less than US$1000 per HLY while almost half (44%) of non-communicable disease interventions had an ACER 
greater than US$1000 per HLY.
Conclusion: The present study shows that several potential cost-effective interventions are available that could 
substantially reduce Ethiopia’s disease burden if scaled up. The use of the World Health Organization’s generalised 
cost-effectiveness analysis tool allowed us to rapidly calculate country-specific cost-effectiveness analysis values for 
159 health interventions under consideration for Ethiopia’s EHSP.
Keywords: Cost effectiveness analysis, Health care rationing, Priority setting, Ethiopia, Essential health services
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Background
Priority setting allows consensus to be reached on 
which interventions to include in an essential health 
service package (EHSP), on which interventions to 
scale up first and on which intervention to scale 
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down [1–3]. In this process, various approaches can 
be applied to compare interventions, of which cost 
effectiveness is the most widely used globally [4]. 
Cost-effectiveness analysis (CEA) plays a central role 
in decision making in many health technology assess-
ment agencies in high-income countries [5], and there 
has recently been a growing interest in using cost 
effectiveness in defining national EHSPs in low- and 
middle-income countries [6].
In the Ethiopian EHSP revision, cost effectiveness 
was a criterion chosen to compare health interven-
tions in terms of value for money [7], but there are 
only a few CEAs of health interventions from Ethiopia 
and other low-income countries. For instance, Hailu 
et al. examine the cost effectiveness of malaria preven-
tion interventions [8], Memirie et  al. examine that of 
maternal and neonatal interventions [9], Strand et  al. 
evaluate that of neuropsychiatric services [10], and 
Tolla et al. examine that of cardiovascular disease pre-
vention and treatment interventions [11].
Most of those studies applied an incremental cost-
effectiveness approach that compares the cost effec-
tiveness of adding new interventions against the 
current practice in the area [12]. This approach 
assumes that the current practice is organised in the 
most efficient way possible and thus does not account 
for existing inefficiencies in the health system. With 
incremental/marginal analysis, it is difficult to exam-
ine whether the current mix of interventions repre-
sents an efficient use of resources [12, 13]. Although 
these pieces of evidence are vital in informing the set-
ting of priorities in decision making in specific sub-
programme areas or for specific diseases, particularly 
when the existing package is assumed to allocate effi-
ciently, they are less relevant in informing the sector-
wide analysis of EHSP revisions [14, 15].
Therefore, the World Health Organization (WHO), 
in its CHOosing Interventions that are Cost Effec-
tive (CHOICE) programme, proposes a generalised 
CEA that compares all interventions with ‘doing noth-
ing’ or a ‘null scenario’ [13]. This approach assesses 
whether the current mix of interventions is efficient 
and whether a proposed new technology or interven-
tion is appropriate. It also provides decision makers 
with information on what they could achieve if they 
reallocated resources in the most efficient way. This 
approach provides broader generalisability of the CEA 
results and is considered an appropriate method for 
redefining an EHSP [13]. Therefore, this paper uses 
the WHO-CHOICE tool to calculate an ACER for the 
159 relevant health interventions for use in the revi-
sion of Ethiopia’s EHSP.
Methods
Study population and context
This study was conducted in Ethiopia in 2019 as part of 
the revision of the country’s EHSP [7]. Ethiopia has a 
large disease burden, with average life expectancy of 65.5 
[16, 17]. Communicable, maternal, neonatal, and nutri-
tional disorders (CMNNDs) represent the greatest dis-
ease burden, accounting for 58% of disability-adjusted life 
year (DALY) loss in 2017. In the same year, the burden 
of NCDs, such as cardiovascular diseases, diabetes and 
cancer, accounted for 34% of the burden. About 8% of 
the DALYs were from emergencies and injuries [17]. Fur-
thermore, Ethiopia is a low-income country, with a Gross 
Domestic Product (GDP) per capita of US$953 in 2019 
[18] and a per capita health expenditure of about US$33 
in 2016/17 [19]. Further reduction or slow increment of 
the health expenditure is expected in Ethiopia because 
of the impact of COVID-19 pandemic on the economic 
growth of the country and its global impact. Therefore, it 
is crucial to invest limited resources efficiently.
Interventions
A breakdown of interventions by the conditions they pre-
vent or treat is provided in Table 1. A total of 1018 inter-
ventions were analysed for the EHSP. The current version 
of the WHO-CHOICE generalised cost-effectiveness 
analysis (GCEA) tool includes about 400 interventions 
[20], of which 159 were found to be relevant for the Ethi-
opian EHSP. We grouped the 159 interventions into 12 
groups that matches with the sub-programme areas clas-
sification of intervention list in the EHSP. In general, and 
slightly over half of them fell under either reproductive, 
maternal, neonatal and child health (RMNCH) (28.3%), 
mental health (12.6%) or policies against NCDs (10.1%), 
such as physical inactivity, excessive alcohol use and 
tobacco, sugar and salt intake (Table 1).
Health effects of the interventions
We used the WHO-CHOICE GCEA tool to analyse the 
country-level health benefits of each intervention [21]. 
This model examines for each disease of interest (by inci-
dence, remission and case fatality rates) how proportions 
of the population transit between health states in the 
presence or absence of an intervention. The Global Bur-
den of Disease disability weights were used to evaluate 
the health state in the time spent in each health state, and 
the health effects generated by each intervention are pre-
sented as healthy life years (HLYs) gained [22].
We applied various integrated impact-modelling 
modules of the latest version of Spectrum software 
to model the health benefits of each intervention [22] 
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and applied the DemProj module to project population 
growth and other underlying demographic parameters 
(Table  1). This module uses World Population Pros-
pects 2017 data from the United Nations Population 
Division. The FamPlan module was used to estimate the 
impact of family planning interventions. In this module, 
we used data from the 2016 Ethiopian Demographic 
Health Survey. We employed the AIDS Impact Mod-
ule (AIM) (which was initially developed by UNAIDS 
to make national and regional HIV estimates every 
2 years) to estimate the impact of interventions against 
HIV, and we employed the TIME Estimates and TIME 
impact Module to estimate the health impact of tuber-
culosis (TB) interventions. For RMNCH, nutrition and 
Water sanitation and hygiene (WASH) interventions, 
the Lives Saved Tool (LiST) module was employed, and 
we used the non-communicable disease impact mod-
ule to calculate the impact of NCD policy interventions 
and other interventions against cancer and respiratory 
disease as well as mental health, neurological and sub-
stance use disorders [22].
The spectrum software includes default input for 
many countries based on data from various sources 
(i.e. systematic reviews, individual studies, national 
and regional reports, GBD etc.). We downloaded and 
used country-specific data for Ethiopia in the Spectrum 
software. The Country Data Package was prepopu-
lated with the total population, population in need, 
target population, disease burden and effect size for 
each intervention. We carefully reviewed all the default 
input with programme area experts at the Ministry 
of Health, and appropriate changes were made when 
deemed necessary. A more detailed explanation of each 
of the intervention input assumptions is provided else-
where [22, 23].
Costs of interventions
The identification, measurement and valuation of the 
costs of all the interventions were conducted from the 
health system’s perspective, accounting for the full cost 
of delivering an intervention, regardless of who cur-
rently pays for it. The ingredients costing approach was 
used, in which each input of delivering the intervention 
is identified and the quantity of each resource required 
by the intervention is multiplied by the unit price of 
each input (i.e., the unit price × quantity approach 
was applied) [12]. In the WHO-CHOICE GCEA tool, 
all the ingredients, based on expert recommendations, 
are provided as default values, and the country team 
reviewed the inputs and made changes when neces-
sary. For example, all the drugs and supplies needed 
to provide each service were systematically identified, 
accounting for the cost of delivering the drugs and sup-
plies from the point of production or purchase to the 
point of use (i.e., the cost of transportation, storage, 
shipment and customs clearance). Default prices for 
drugs and suppliers within the GCEA tool are taken 
from an international drug price database (MSH). We 
updated the prices of some drugs and supplies based 
on data from the Ethiopian Pharmaceutical Supply 
Agency and the Logistics Department of the Ministry 
of Health. To account for the cost of delivering drugs 
and supplies, an average mark-up of 6% of the price was 
generally taken. For drugs needing a cold supply chain, 
Table 1 Frequency and proportion of interventions evaluated by sub-programme area, 2019
The level of detail varies across the sub-programme areas
Intervention by sub-programme area N % Spectrum impact model used
RMNCH 44 28.3 LiST, FamPlan
Mental health 20 12.6 NCD impact
Policy interventions on NCDs 16 10.1 NCD impact
Cervical cancer 13 8.2 NCD impact
Respiratory disease 12 7.6 NCD impact
Colorectal cancer 11 6.9 NCD impact
Breast cancer 10 6.3 NCD impact
Tuberculosis 10 6.3 TIME Estimates and TIME impact
Nutrition 9 5.7 LiST
HIV/AIDS 5 3.1 AIM and GOALS
Malaria 5 2.5 LiST
Water hygiene and sanitation 4 2.5 LiST
Total 159 100
Page 4 of 13Eregata et al. Cost Eff Resour Alloc            (2021) 19:2 
an additional 13% of the cost of the drug was taken as 
mark-up as the cold-chain system incurs an additional 
cost. For Long-lasting Insecticidal Nets (LLINs), a 26% 
mark-up was taken as LLINs are relatively bulky and 
their transportation, loading and unloading incur an 
additional cost [24].
Health personnel costs for providing the interventions 
were also included. The salary scale of the health work-
force, such as the salaries and benefits of nurses, doctors 
and pharmacists, was based on the most up-to-date data 
from the Human Resource Department of the Ministry 
of Health of Ethiopia. Staff time use was calculated on 
the assumption that, on average, each person works 8 h 
per day over 230 working days per year. Inpatient cost 
per day and outpatient cost per visit were taken from the 
WHO-CHOICE model [25].
Programme costs were also included in this analysis 
[24]. Programme costs are the non-health care delivery 
costs associated with delivering an intervention pro-
gramme that are incurred at a level other than the inter-
vention’s point of delivery. They include costs incurred 
at district, provincial or central levels and exclude costs 
incurred at facility or patient levels. They include the cost 
of administration and planning, media and communica-
tion, law enforcement, training, monitoring and evalua-
tion. All costs were valued using 2019 US dollars (USDs). 
All cost input data originally collected in Ethiopian Birr 
(ETB) were first converted to USD using the average 
exchange rate for the year and were later converted to 
2019 USD using the GDP deflator.
Cost-effectiveness analysis
To account for the impact of an intervention in the long 
term (steady state), we followed in this cost-effective-
ness analysis model a hypothetical Ethiopian population 
cohort over a 100-year time horizon starting in 2019. 
The average cost effectiveness of the intervention was 
computed as a ratio of the total cost of the intervention 
to total health life years (HLYs) gained from the inter-
vention [12, 26]. The interventions were ranked and 
compared based on their ACERs. Both costs and health 
outcomes were discounted at an annual rate of 3% [13].
Cost-effectiveness thresholds
A cost-effectiveness threshold (CET) is an explicit cut-
off point for assessing the opportunity cost of interven-
tions, with interventions having a cost-effectiveness ratio 
below the threshold being considered to offer good value 
for money [27]. There is a long-standing debate concern-
ing the CET [18, 28, 29]. In the case of sector-wide analy-
sis of health interventions using a GCEA, a CET is not 
required because the purpose of a GCEA is to compare 
the whole list of interventions against the comparator of 
doing nothing, and the ACERs of interventions should 
be compared with one another, even across programme 
areas, and not against a predefined CET [14, 15]. In this 
study, therefore, we did not apply a CET; instead, we 
report the ACERs in ascending order in bar graphs for 
each programme area. However, we use US$100 and 
US$1000 per HLY gained as references to summarise and 
present the ACER results.
Table 2 Summary of ACERs (USD per HLY) of the interventions by sub-programme areas
SD: standard deviation; p25: 25th percentile; p75: 75th percentile; Min: minimum; Max: Maximum; % < $1000: proportions of interventions within that program area 
with ACERs lower than $1000 per HLY
Sub-programme Mean SD Median p25 p75 Min Max % < $1000
HIV/AIDS 106 167 34 20 61 13 403 100
RMNCH 116 258 37 13 113 0.4 1591 97
WASH 122 219 16 9 234 5 451 100
Tuberculosis 143 12 139 137 147 129 163 100
Nutrition 262 312 72 37 580 31 746 100
Cervical cancer 870 1818 111 36 628 34 6534 77
Mental health 1045 1944 185 120 944 31 7610 75
Malaria 1163 1186 1310 79 1469 40 2915 40
NCD policy interventions 1834 2759 437 202 3053 26 9115 69
Breast cancer 2157 1895 1535 1032 2203 366 6104 20
Chronic respiratory diseases 2307 3344 809 368 1484 164 8856 50
Colorectal cancer 3920 1967 4646 2493 5436 783 5602 18
Overall 1014 1926 151 40 783 0.4 9115 75
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Results
In this study, we identified cost-effectiveness estimates 
for 159 interventions. An overview of the distribution of 
the ACERs is presented in Table 2. Of the total number 
of interventions evaluated in this study, 58 (37%) have an 
ACER of less than US$100 per HLY, 104 (65%) have an 
ACER of less than US$500 per HLY and 119 (75%) have 
an ACER of less than US$1000 per HLY gained.
Five interventions (basic palliative care for colo-
rectal cancer, colorectal cancer treatment at stage 4, 
relapse prevention medication for alcohol use/depend-
ence, inhaled short-acting beta-agonist for intermittent 
asthma and theophylline + high-dose inhaled beclometa-
sone + short-acting beta-agonist for asthma) have an 
ACER above US$10,000 per HLY. Therefore, in the sum-
mary statistics provided in Table 2, we exclude these five 
interventions as they represent extreme values.
We estimated ACERs ranging from less than US$1 per 
HLY gained (for family planning) to about US$48,000 per 
HLY gained (for treatment of stage 4 colorectal cancer). 
A large majority (97%) of RMNCH and infectious dis-
ease interventions had an ACER of less than US$1000 per 
HLY, and a substantial proportion (44%) of NCD inter-
ventions had an ACER of greater than US$1000 per HLY 
(Table 2).
We present the full costs and effectiveness of all the 
interventions in supplement table (Additional file  1). 
Below, we present the key findings for major programme 
areas.
Cost effectiveness of RMNCH interventions
All RMNCH interventions except zinc supplementation 
(ACER = 1591 USD/HLY) and ectopic pregnancy case 
management (ACER = 685 USD/HLY) had an ACER of 
less than US$400 per HLY (Fig. 1). The three most cost-
effective interventions in this category are prevent-
ing and managing unplanned pregnancy (ACER = 0.41 
USD/HLY), provision of family planning services alone 
Fig. 1 ACERs for RMNCH (Trimmed at US$350)
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(ACER = 0.42 USD/HLY) and provision of skilled assis-
tance for normal delivery, including postpartum family 
planning (ACER = 0.47 USD/HLY). All immunisation 
interventions cost less than US$100 (e.g., the Hib vac-
cine costs 49 USD/HLY, routine EPI + additional vac-
cines cost 68 USD/HLY and pneumococcal vaccine 
costs 86 USD/HLY).
Cost effectiveness of HIV/AIDS, TB and malaria 
interventions
All the HIV/AIDS interventions had an ACER of less 
than US$100 per HLY gained except cotrimoxazole 
for children, which costs US$403 per HLY. Paediatric 
anti-retroviral therapy (ART) costs US$20 per HLY, 
Prevention of Mother to Child Transmission (PMTC) 
of HIV costs US$61 per HLY, ART for adult women 
costs US$13 per HLY and ART for adult men costs 
US$34 per HLY. In this study, we evaluated four anti-
malaria interventions. While the use of insecticide-
treated materials costs US$79 per HLY and indoor 
residual spraying costs US$40 per HLY, Intermittent 
Preventive Therapy (IPT) for pregnant women costs 
US$1310 per HLY and treatment of malaria for preg-
nant women costs US$1469 per HLY. The 10 TB inter-
ventions evaluated in this study have ACERs ranging 
from US$129 per HLY (for the detection and treatment 
of multidrug-resistance tuberculosis (MDR-TB) using a 
smear or culture) to US$163 per HLY (for the detection 
and treatment of TB using a combination of smear and 
Xpert) (Fig. 2).
Of the 13 WASH and nutrition interventions in this 
study, the three most cost-effective were use of a water 
connection in the home (ACER = US$5 per HLY), 
handwashing with soap (ACER = US$13 per HLY) and 
improved excreta disposal (latrine/toilet) (ACER = US$13 
per HLY). Intermittent iron-folic acid supplementa-
tion for menstruating women where anaemia is a public 
health problem costs US$746 per HLY (Fig. 3).
Fig. 2 ACERs for HIV, TB and malaria interventions (Trimmed at US$500)
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Cost effectiveness of NCD policy interventions
For the 16 policy interventions against NCDs evaluated 
in this study, the ACERs range from a high of US$9115 
per HLY gained (for prevention of hazardous alcohol use 
using legal enforcement to restrict alcohol advertising) 
to a low of US$26 per HLY gained (for reduction of salt 
intake by harnessing/involving industries for reformula-
tion). Most of the tobacco prevention interventions were 
very cost effective. For instance, the ACER for protect-
ing people from tobacco smoke was US$232 per HLY 
while warning about the danger of tobacco using labels 
costs US$411 per HLY. The ACER for warning people 
about the danger of tobacco through mass media cam-
paigns was US$515 per HLY gained, for enforcing bans 
on tobacco advertising US$105 per HLY gained and for 
enforcing youth access restrictions on tobacco US$1728 
per HLY gained.
Intervention to enforce restrictions on the availability 
of retailed alcohol was US$4377 per HLY gained while 
screening and brief intervention for hazardous and 
harmful alcohol use was only US$579 per HLY gained. 
Most of the salt intake restriction interventions have the 
lowest cost-effectiveness ratios for Ethiopia. For instance, 
adopting standards in front-of-pack labelling costs US$42 
per HLY. Providing education and communication costs 
US$333 per HLY, and pursuing salt reduction strategies 
in community-based eating spaces costs US$173 per HLY 
gained (Fig. 4).
Cost effectiveness of cancer interventions
All the early detection and screening interventions for 
cervical cancer cost less than US$100 per HLY. For exam-
ple, a Papanicolaou test (Pap smear) costs US$34, visual 
inspection with acetic acid (VIA) costs US$35 and the 
HPV-DNA test costs US$60 per HLY gained. However, 
screening of breast cancer with clinical examination costs 
US$2203 per HLY and with mammography US$6104 per 
HLY. Similarly, colorectal cancer screening with sigmoi-
doscopy costs US$2493 and with colonoscopy US$5418 
per HLY (Fig. 5).
Cost effectiveness of mental health interventions
In this study, we examined 20 mental health interven-
tions. The provision of basic psychosocial treatment for 
mild depression is the most cost-effective intervention, 
with an ACER of US$31 per HLY, and basic psychosocial 
support for mild cases of anxiety disorder is the second 
most cost-effective (ACER = 67 USD/HLY). In the mental 
Fig. 3 ACERs for nutrition and WASH interventions
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health intervention category, relapse prevention medica-
tion for alcohol use/dependence is the least cost-effective 
intervention, costing US$37,616 per HLY (Fig. 6).
Cost effectiveness of chronic respiratory disease 
interventions
We examined 12 interventions under the chronic res-
piratory disease category, and the provision of smoking 
cessation interventions to prevent chronic obstructive 
pulmonary disease (COPD) is the most cost effective 
(ACER = 164 USD/HLY). The provision of an inhaled, 
short-acting beta-agonist for intermittent asthma is the 
least cost-effective in this category, with an ACER of 
US$15,440 per HLY (Fig. 7).
Discussion
This analysis aimed to provide input for the revision 
of Ethiopia’s EHSP, which used seven predefined and 
pre-agreed criteria, one being the cost effectiveness of 
interventions [7]. Our analysis encompasses a compre-
hensive range of health interventions, including preven-
tive, promotive, curative and policy interventions. Of 
the interventions analysed in this study, a large majority 
(75%) have ACERs of less than US$1000, and 36% have 
ACERs below US$100.
Cost-effectiveness analysis is an increasingly impor-
tant prioritisation tool. The cost-effectiveness evidence 
for redefining Ethiopia’s EHSP was generated in three 
ways: by contextualising CEA evidence from other stud-
ies using transferability criteria, by using expert opinion 
for multisectoral interventions and by using the WHO 
GCEA tool [7]. Using this tool, we provide cost-effec-
tiveness evidence for 159 relevant health interventions 
for EHSP revision in Ethiopia. We believe that other 
low-income countries in Africa can also generate these 
pieces of evidence within a relatively short time and at an 
affordable cost compared with individual economic eval-
uation studies.
We provide cost-effectiveness evidence for 77 inter-
ventions on RMNCH and infectious disease (e.g., HIV, 
TB, nutrition, malaria and WASH) and for 82 interven-
tions on NCDs. In general, a majority of the interven-
tions have relatively low ACERs of less than US$1000 per 
HLY gained. However, when we disaggregate the finding 
Fig. 4 ACERs for NCD policy interventions
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by programme area, the results are mixed. While a vast 
majority (95%) of RMNCH and infectious disease inter-
ventions have an ACER of less than US$1000 per HLY, a 
substantial proportion (44%) of NCD interventions have 
an ACER of higher than US$1000 per HLY. In general, 
findings from our study are consistent with findings of 
other country specific studies in Ethiopia, Zimbabwe, 
Mexico [8–10, 30–32], or other regional and global esti-
mates [33–38]. However, head to head comparison of the 
ACERs and further examination of cost, effectiveness, 
and its driving factors remain a priority for additional 
research.
Family planning interventions, for example, are the 
most cost effective in this study, with ACERs of less 
than US$1 per HLY gained. This very low ACER may be 
partly explained by the fact that the model accounts for 
a reduction in unplanned pregnancies and an associated 
reduction in maternal mortality. Most of the interven-
tions targeting infectious diseases were cost effective, 
with an ACER of less than US$500 per HLY. For example, 
we evaluated four HIV/AIDS interventions, and they all, 
except the provision of cotrimoxazole for children, have 
an ACER of less than US$100 per HLY gained. The rela-
tively low ACER in this study may partly reflect the dec-
rement of the price of ART drugs as is shown in several 
recent studies [39, 40].
Addressing maternal, neonatal and child health issues 
is a top priority of the Ethiopian Ministry of Health 
(MoH) [7]. In our study, the majority of the interven-
tions on RMNCH were very cost effective, with an 
ACER value of less than US$200 per HLY gained. This 
finding is in line with that of Memirie et  al. in a CEA 
examining the cost effectiveness of 13 maternal and neo-
natal health (MNH) interventions in Ethiopia. Although 
not a GCEA and therefore not directly comparable, that 
study found that 12 of 13 MNH interventions had an 
Fig. 5 ACERs for cancer interventions (Trimmed at US$10,000)
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incremental cost-effectiveness ratio of less than US$400 
per HLY [9].
Most of the preventive NCD policy interventions have 
a lower cost-effectiveness ratio than the treatment NCD 
interventions. A substantial proportion (44%) of NCD 
interventions have an ACER of greater than US$1000 per 
HLY. This relatively high ACER may reflect the fact that 
the treatment cost for chronic NCD is higher and the 
Fig. 6 ACERs for mental health interventions (Trimmed at US$10,000)
Fig. 7 ACERs for chronic respiratory disease interventions (Trimmed at US$10,000)
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treatment effectiveness lower than for the other interven-
tions. This is particularly consistent with findings from a 
comprehensive, but relatively old study, examining 101 
NCD interventions in Mexico. The study find similar var-
iations among NCD policy interventions and NCD treat-
ment interventions as we do [30].
Strengths and limitations
By applying the GCEA approach, it is possible to evalu-
ate whether the current mix of interventions is efficient 
and whether proposed new interventions are appropri-
ate. Therefore, GCEA is a more appropriate approach 
than a marginal analysis for conducting a sector-wide 
cost-effectiveness analysis of interventions [14, 15]. In 
this study, which included 159 interventions from diverse 
programme areas, we conducted a sector-wide cost-effec-
tiveness analysis. Although this study covers a substan-
tial number of crucial interventions, it did not attempt 
to analyse all interventions in the Ethiopian health sec-
tor. We believe, however, that our findings can be used 
as benchmarks for making better-informed expert judge-
ments on other interventions that could not be analysed 
in such a standardised way.
WHO-CHOICE GCEA tool is important tool for sec-
tor-wide analysis of cost-effectiveness of wider range of 
interventions for priority setting. A primary advantage of 
the WHO-CHOICE GCEA tool is the ability to compare 
many interventions at the same time based on the same 
assumptions on cost, disease epidemiology and other key 
health system parameters (e.g., human resource, financ-
ing, and infrastructure). When health system plans and 
strategies are designed, we should evaluate and compare 
the costs and outcomes of combinations of interven-
tions. However, a barrier to conducting economic evalua-
tion studies is that they are time consuming and demand 
large amounts of local data and local technical expertise. 
We believe that this study demonstrates that the existing 
platform, with a large support team and substantial com-
mitment, makes such an extensive and comprehensive 
evaluation possible.
Our work has other limitations. First, in this study, we 
used the health system perspective. In Ethiopia, one-
third of the total health care cost is covered by the out-
of-pocket expenditure of individuals [19], which can 
influence individuals’ choices in accessing health care 
delivery. The choice of perspective should also be taken 
into consideration when interpreting the results. Second, 
in this GCEA study, we applied data from diverse sources 
to model the health impact of interventions and costs. Of 
course, modelling is inevitably an imperfect representa-
tion of reality, and, therefore, robust uncertainty analysis 
would to some extent alleviate this challenge. However, 
because of the vast number of interventions included 
in this analysis, we did not include a sensitivity analysis. 
Therefore, as the software expands, future GCEA analy-
sis of this kind should integrate a sensitivity analysis of 
at least some of the critical drivers of costs and health 
impacts.
A third limitation of this study is the use of DALYs 
for estimating disease burden and health benefit. Crit-
ics of DALY argue that the measure itself has limita-
tions [41, 42]. Using DALYs tends to underrepresent 
or overestimate the value of interventions (such as pal-
liative care and family planning) with outcomes that are 
not readily measured in this metric as well as interven-
tions in nutrition for which the outcomes are improved 
cognition rather than improved health [43]. This is a real 
limitation that was taken seriously in the revision of Ethi-
opia’s EHSP. For these interventions, we also relied on 
the expanded EHSP process with user involvement and 
expert judgements. Furthermore, criteria other than cost 
effectiveness, such as equity, financial risk protection, 
budget impact and public concern are also important for 
defining the EHSP [3]. A fourth limitation of this study 
is that the models used do not capture full health ben-
efits. The most striking example is the LiST model which 
mainly considers mortality outcomes. Future analysis 
should also account for health benefits from RMNCH 
interventions that avert non-fatal conditions.
Additionally, there are gaps in the available evidence 
on the cost of interventions, which can be closed only 
by conducting substantially more research in developing 
countries. Therefore, we recommend a concerted effort 
to establish country-level cost databases. This could be 
combined with capacity building through the training of 
researchers to generate such evidence.
Conclusion
Through the process described above, we calculated 
country-specific CEA values which were required to 
inform the decisions around which interventions to pro-
vide under Ethiopia’s essential health service package 
(EHSP). The present study shows that several potential 
cost-effective interventions are available in all program 
areas that could substantially reduce Ethiopia’s disease 
burden if scaled up.
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ABSTRACT
To make progress toward universal health coverage, countries should define the type and mix of 
health services that respond to their populations’ needs. Ethiopia revised its essential health services 
package (EHSP) in 2019. This paper describes the process, methodology and key features of the new 
EHSP. A total of 35 consultative workshops were convened with experts and the public to define the 
scope of the revision, develop a list of health interventions, agree on the prioritization criteria, gather 
evidence and compare health interventions. Seven prioritization criteria were employed: disease 
burden, cost effectiveness, equity, financial risk protection, budget impact, public acceptability and 
political acceptability. In the first phase, 1,749 interventions were identified, including existing and 
new interventions, which were regrouped and reorganized to identify 1,442 interventions as relevant. 
The second phase removed interventions that did not match the burden of disease or were not 
relevant in the Ethiopian setting, reducing the number of interventions to 1,018. These were evaluated 
further and ranked by the other criteria. Finally, 594 interventions were classified as high priority (58%), 
213 as medium priorities (21%) and 211 as low priority interventions (21%). The current policy is to 
provide 570 interventions (56%) free of charge while guaranteeing the availability of the remaining 
services with cost-sharing (38%) and cost-recovery (6%) mechanisms in place. In conclusion, the 
revision of Ethiopia’s EHSP followed a participatory, inclusive and evidence-based prioritization 
process. The interventions included in the EHSP were comprehensive and were assigned to health 
care delivery platforms and linked to financing mechanisms.   
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Introduction
In 2015, all United Nations Member States adopted 
the Sustainable Development Goals (SDGs) to guide 
policies and actions across all sectors that are impor-
tant to development. SDG-3 is the health goal, and 
SDG target 3.8 specifically concerns achieving uni-
versal health coverage (UHC) for all segments of 
the population.1 The World Health Organization 
(WHO) defines UHC as a condition in which “all 
people and communities can use the promotive, pre-
ventive, curative, rehabilitative and palliative health 
services they need, of sufficient quality to be effective, 
while also ensuring that the use of these services does 
not expose the user to financial hardship.”2 To make 
tangible progress toward UHC, countries should 
clearly define the essential health services that they 
can deliver to their population within the available 
budget and without financial risk whilst also clearly 
defining how they plan to scale up coverage, reduce 
direct costs and expand the range of health interven-
tions in the future.3–7 An interventions is defined as 
“an act performed for, with or on behalf of a person 
or population whose purpose is to assess, improve, 
maintain, promote or modify health, functioning or 
health conditions.”8
The selection of high-impact, priority interven-
tions is important but has never been easy. Hard 
decisions must be made in situations with limited 
resources and high demands on health services. 
The decision should take into account the current 
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level of human and financial resources available, 
as well as practical constraints.9,10 WHO and 
others, recommend systematic priority-setting 
that employs explicitly defined and agreed upon 
prioritization criteria, using evidence from all 
available sources and relying on participatory and 
democratic processes.6,11-13 Explicit priority setting 
is more important than ever to agree on essential 
universal health services and reach consensus on 
how to finance them, whether through full public 
financing, cost-sharing or cost-recovery.13
The revision of the Ethiopian essential health 
services package (EHSP) can be seen as a key activ-
ity to accelerate the progressive realization of UHC 
for all Ethiopian citizens.14,15 In 2018, a decision 
was made to revise the EHSP, which Ethiopia had 
first developed in 2005.16 Since then, the disease 
burden profile of the country had changed due to 
a growing number of non-communicable diseases 
(NCDs) to which the package did not adequately 
respond.17 Furthermore, the population’s demand 
for health services had increased substantially, and 
several interventions had been introduced to the 
health system on an ad-hoc basis without formal 
evaluation.18 Arguably, rolling out health interven-
tions without a well-defined assessment of their 
costs and impact on health, equity, and financial 
risk could lead to the inclusion of ineffective inter-
ventions that replace services more crucial to UHC 
targets.
Recognizing the importance of clearly defined 
health intervention priorities to achieving UHC, the 
Ministry of Health (MoH) of Ethiopia revised the 
EHSP from May 2018 through November 2019.19 
This paper describes the revision process, the key 
methodology, the involvement of stakeholders and 
experts and the most important features of the new 
Ethiopian EHSP.
The paper is organized as follows: First, we 
describe the country context and the scope and 
objectives of the revised EHSP. Second, we describe 
the elements of the revision process (Figure 1), 
including its organization (the governance of the 
revision process), the identification of relevant 
health interventions, the selection of prioritization 
criteria, evidence synthesis, the comparing and 
ranking of interventions, the impact of costing 
and budget and the formulation and revision of 
the intervention list. Third, we describe the final 
revised EHSP. Finally, we compare and discuss the 
Ethiopian process and results with similar work in 
other countries.
Country Context
Ethiopia is the second-most populous nation in 
Africa, with a total population of about 
108 million.20 Approximately 83% of the popu-
lation lives in rural areas, and their livelihood is 
mainly dependent on subsistent agriculture. 
Almost a quarter of the population lives below 
the poverty line, and the country’s per capita 
income is only 953 USD.21,22 Furthermore, per 
capita health expenditure in Ethiopia is very low 
at only 33 USD in 2016/2017.23
Figure 1. The roadmap for the revision process of Ethiopia’s EHSP
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Ethiopia is a federal state organized into nine 
semi-autonomous regions and two chartered 
cities (Addis Ababa, the capital, and Dire Dawa, 
a major city in eastern Ethiopia). The federal 
MoH is responsible for the formulation of health 
policies—including the definition of the EHSP— 
for the health sector. The regional health bureaus 
are the main implementers of the programs.18
Scope and Objectives of the Revised EHSP
The scope of the revised EHSP reflects the national 
health policy and its SDG-UHC commitments while 
taking into account the constraints of resource avail-
ability and economic growth. The EHSP has four 
basic features. First, it was designed to address the 
health needs of the Ethiopian population across the 
whole life course regardless of income, gender or 
residence (urban/rural). Second, it was designed to 
be delivered at all levels of service (i.e., primary, 
secondary and tertiary). Third, the package was 
designed to serve for five years (2020–2025) with 
regular revision every five year. Fourth, it includes 
promotive, preventive, curative and rehabilitative 
interventions.
The primary objective of the revised EHSP is to 
reduce the burden of disease in Ethiopia by making 
high priority interventions available and affordable. 
It also aims to protect people from catastrophic 
health expenditures, increase equitable access to 
health services, improve the efficiency of the health 
system and increase public participation and trans-
parency in decision-making in the health sector.
Governance of the Revision Process
The MoH initiated the revision of the EHSP, and 
eight inception meetings were held from June– 
August 2018 to outline the EHSP revision plan, 
define the revision roadmap and determine the 
scope and objectives of the revised EHSP.14 The 
existing MoH governance structure for decision- 
making was applied. All directorates at the MoH 
and representatives of all regional health bureaus 
were involved throughout the process to ensure 
inclusiveness and transparency. Additionally, 
national and international experts (WHO and 
Disease Control Priorities–Ethiopia) provided 
technical support throughout the process.
An EHSP core team, comprising a health econo-
mist, health systems specialist and epidemiologist, was 
organized by the minister to execute and coordinate 
the work. The core team’s role was to facilitate the 
development of the entire package, including the 
development of a prioritization protocol, the collation 
of data, evidence synthesis, stakeholder engagement, 
and costing and fiscal space analysis. A technical 
working group (TWG) was established comprising 
30 senior experts on various health system dimen-
sions. The TWG supported the core team in the pre-
paration of the revision roadmap, which helped to 
establish a common understanding among the stake-
holders on the steps necessary to achieve an evidence- 
based revision of the package (Supplement I). As 
a result, a detailed plan of the revision process and 
the methods to be used were presented by the TWG to 
the MoH leadership and approved (Figure 1). The 
core team and TWG followed, with slight modifica-
tions, the steps of the health benefits package design 
recommended by Glassman et al.24
Identification of Relevant Health 
Interventions
The first step was to create a list of health interven-
tions for consideration, including the promotive, 
preventive, curative and rehabilitative interventions 
relevant to Ethiopia. An exhaustive search of the 
Ethiopian health sector’s plans, strategies and 
national publications was conducted along with 
reviews of the WHO intervention compendium 
(forthcoming) and the third edition of Disease 
Control Priorities (DCP3).25 Subsequently, a two- 
day workshop was held to identify additional inter-
ventions. Eighty experts from various program areas, 
primary health care practitioners, doctors and spe-
cialists identified and proposed all health services 
relevant to the Ethiopian context. Furthermore, 
existing levels of coverage and availability of service 
were considered during the interventions listing 
process.
Stakeholder Engagement
The acceptability and legitimacy of the EHSP will 
depend not only on the type and quality of evidence 
used to define the package but also on the transpar-
ency and deliberativeness of the revision process. 
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Legitimacy and trust crucially depend on a delibera-
tive process with stakeholder involvement.26 
Stakeholders were actively engaged in matters ran-
ging from setting prioritization criteria and identify-
ing health interventions to the prioritization and 
ranking of the interventions. The stakeholders 
included local experts, such as primary health care 
practitioners, doctors and specialists, as well as public 
representatives, including a women’s association, 
a youth association and various professional associa-
tions. The latter included the Ethiopian Medical 
Association, Ethiopian Society of Obstetrics and 
Gynecologists, Ethiopian Surgical Association, 
Ethiopian Radiology Association, Ethiopian Public 
Health Association, Ethiopian Public Health Officer 
Association and Ethiopian Environmental Health 
Association as well as disease-specific interest groups, 
including the Diabetic Association, the Union of 
People Living with HIV, the Cardiac Disease 
Association, the Cancer Disease Association, the 
Kidney Disease Association, and the Association of 
People Affected by Leprosy (Supplement II). A total 
of 35 consultative workshops were convened with 
experts and the public to define the essential health 
service package.
Prioritization Criteria
The prioritization criteria were prepared by reviewing 
the literature, national health policy documents and 
relevant strategic health sector documents. Also con-
sidered were the criteria for the prioritization of health 
services recommended by WHO’s Consultative 
Group on Equity and Universal Health Coverage, 
including maximizing the total health gains for 
a given investment, giving priority to health services 
that target or benefit the less fortunate and providing 
financial risk protection, particularly to the poor.13 
Broadly, such a prioritization approach is based on 
three elements: data, dialogue and decision.27 Ten 
consultations and deliberative meetings were held on 
the proposed criteria with global and local experts, 
public representatives and professional associations.
After the deliberations, seven prioritization cri-
teria were selected, namely the burden of disease, 
cost-effectiveness, equity, financial risk protection, 
budget impact, public acceptability and political 
acceptability. Disease burden was used to identify 
the relevant conditions and risk factors of 
particular importance in the Ethiopian context. 
The cost-effectiveness criterion was used to quan-
titatively rank and compare health interventions 
according to the health gains that they would 
yield per dollar spent. The equity and financial 
risk protection criteria were used to further com-
pare health interventions and to give higher values 
to health benefits for the less fortunate and to 
interventions that protect against catastrophic out- 
of-pocket health expenditures. In addition, the 
public and political acceptability of the interven-
tions were taken into account through the quali-
tative deliberative process and a dialogue with 
policy makers.
Assessment and Synthesis of Evidence
Cost-effectiveness evidence was estimated using 
a mix of methods, including both new, context- 
specific analysis and a literature review. For 144 
interventions, WHO’s CHOosing Interventions that 
are Cost-Effective (CHOICE) methodology for gen-
eralized cost-effectiveness analysis (GCEA) was used 
to estimate average cost-effectiveness ratios (ACERs) 
using local input data. For 382 interventions, we used 
CEA evidence from the literature, such as the 
DCP3,25 the Tufts CEA Registry,28 and peer- 
reviewed articles after applying appropriate contex-
tualization to the Ethiopian context using general 
transferability criteria based on the Consolidated 
Health Economic Evaluation Reporting Standards 
10-point checklist.29 The articles were searched 
using keywords constructed with a combination of 
the intervention’s name, the study location (with 
priority given to studies done in Ethiopia or another 
low-income setting), and time (prioritizing recent 
studies). Two independent reviewers appraised the 
studies, and those deemed to meet a minimum stan-
dard of quality were accepted for inclusion in the 
evidence base. For the rest of the interventions (492), 
expert opinions were applied (Table 1). For the CEA, 
the health system perspective was taken, and only 
data that were transferable to the Ethiopian context 
were used. When cost information was originally 
from another setting, the currency difference 
was adjusted using the appropriate exchange rate 
and inflated to 2019 USD using the GDP deflator. 
Healthy life years (HLY) gained, Disability-Adjusted 
Life Years (DALYs) averted and Quality-Adjusted 
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Life Year (QALYs) gained were the main health out-
come measures. All costs and health outcomes were 
discounted at 3% per year.30,31
The interventions were first ranked according to 
cost effectiveness and then adjusted if the interven-
tions had a high equity score and/or financial risk 
protection (FRP) score. The scores for equity impact 
and FRP were assigned through the Delphi process 
with input from subject matter experts, professional 
associations and public representatives. In the revi-
sion of the Ethiopian EHSP, the equity criterion was 
applied in a way that gives high priority for health 
interventions targeting diseases, conditions or risk 
factors which mainly affects the worse off. Based on 
a review of national policy and strategic documents 
in the Ethiopian health sector, the worse-off was 
defined as being children less than five years of age, 
pregnant mothers, the economically poor, and popu-
lations who live in very remote areas. The equity 
score and FRP score ranged from 1 (lowest) to 5 
(highest), with 1 indicating no equity impact/no 
financial risk and 5 indicating that it would be 
inequitable not to include the intervention and that 
people would pay large sums out of pocket. 
Therefore, all the interventions were ranked in des-
cending order based on their priority score, and the 
most cost-effective, equitable and financially protec-
tive health interventions were ranked accordingly 
and included in the EHSP as high-, medium- and 
low-priority interventions.19
Budget Impact
The gap between aspirational targets and available 
financial and physical resources is a rate-limiting 
factor in the implementation of EHSPs in many 
countries. The set of services to be made available 
was determined by the expected available budget. 
Therefore, conducting a costing exercise for the 
whole EHSP and, in particular, per health inter-
vention was an important step.
The costing was done using the OneHealth Tool 
(OHT) for which the default setup includes 438 of 
the 1,018 interventions.32 We manually estimated 
the costs of the remaining 580 interventions in the 
EHSP using an Excel spreadsheet.33 The OHT’s 
default data on the cost of drugs, supplies and the 
default population model for Ethiopia were updated 
with local country-level data.25
The budget impact and the number of interven-
tions the health system needs and can provide depend 
on both the number of individuals in need and the 
intervention coverage. The population in need was 
estimated from the total number of individuals 
affected by the condition and the proportion of 
those who needed the appropriate intervention. We 
used estimates of prevalence and incidence data from 
national-level estimates and employed baseline UHC 
coverage data as published by Eregata et al., supple-
mented by expert judgments when necessary.34
Deliberation and Decisions on the  
Intervention List
The core team undertaking the evaluation presented 
the full results to the policy makers at MoH for 
review, for discussion of whether to include or 
exclude certain interventions and for approval. The 
final decision was taken by the executive committee 
(EC) of the MoH, which is the higher-level decision- 
making body in the sector.
Results
Interventions in the Final Revised EHSP
In the first comprehensive list, 1,749 interventions 
were included for consideration. This initial list was 
then further revised to avoid duplication and merged 
to 1,442 interventions. Various directorates of the 
MoH then commented on the intervention list. We 
further compared the interventions with the magni-
tude of the burden of disease or the risk factor they 
targeted. After removing interventions unmatched by 
the burden of disease or not relevant in the Ethiopian 
Table 1. Summary of the sources of evidence for prioritization in 
the Ethiopian EHSP, 2019
Criterion Evidence synthesis method
Disease burden Global Burden of Diseases (GBD), 2017 study
CEA GCEA study using WHO-CHOICE OneHealth 
Tool, literature search and transferability
Equity Expert opinion using the Delphi method
FRP* Expert opinion using the Delphi method
Budget impact Costing and budget impact analysis 
Annual cost per capita
Public acceptability Deliberative meetings with public 
representatives.
Political acceptability Deliberative meetings with policy makers; 
decisions by EC, MC, and JSC
* Financial risk protection. 
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setting, the number of interventions was reduced to 
1,223. Finally, another regrouping and reorganizing of 
health interventions yielded 1,018 interventions that 
were ready for evaluation and comparison based on 
the other criteria (Supplement III). The interventions 
by the major program are presented in Figure 2.
The interventions by the sub-program area are 
presented in Table 2.
Level of Priority
A decision was taken to make available all 1,018 
interventions in the EHSP. Among them, 594 (58%) 
were categorized as a high priority, 213 (21%) as 
a medium priority and 211 (21%) as low priority 
interventions (Figure 3).
Delivery Platforms
About 60% of the interventions will be delivered 
through what, in Ethiopia, is defined as primary 
care (which includes community-based interven-
tions, health posts, health centers and primary hos-
pitals), about 20% at the secondary level of care and 
about 20% at the tertiary level (Figure 4). When we 
disaggregate the program areas, 70% of the 
RMNCH interventions will be delivered at the pri-
mary care level, while only 30% will be delivered at 
the secondary or tertiary level of care. For hygiene 
and environmental health, 84% of the interventions 
will be delivered as primary care, and, for health 
education and promotion, the figure is 86%. On the 
other hand, 53% of the more advanced NCD and 
surgical interventions will be delivered in secondary 
and tertiary hospitals.
Payment Mechanism
The current policy is to provide 570 interven-
tions (56%) free of charge while the remaining 
services will have a guaranteed availability but 
with cost-sharing (38%) and cost-recovery (6%) 
mechanisms in place (Figure 5). All the inter-
ventions under the program areas of multisec-
toral and health education will be provided free 
of charge while all the interventions under emer-
gency and critical care will be provided with 
cost-sharing
Discussion
With a long-term goal of reaching UHC, Ethiopia 
revised the EHSP in 2019.19 In light of the globally 
recommended approaches and principles for 
designing a good EHSP,12,13,24,35-37 we discuss the 
process of revision, the key methodology, the 
involvement of stakeholders and experts and the 
key features of the new Ethiopian EHSP.
Figure 2. The proportion of interventions by major program area
Notes: BCC = behavioral change communication; NCD = non-communicable diseases; NTD = neglected tropical disease; 
RMNCH = reproductive maternal neonatal child health. 
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Participatory Process
As recommended by Norman Daniels in the account-
ability for reasonableness framework, an effort was 
made to ensure that the whole process of EHSP 
revision in Ethiopia was as open, fair, participatory 
and inclusive as possible.35 The revision process 
took about 1.5 years (from May 2018 through 
November 2019). Most of the internal and external 
stakeholders were actively engaged from the inception 
to the finalization of the EHSP. Five rounds of work-
shops were conducted with policy makers at the regio-
nal and federal levels in the health sectors, including 
ministers, state ministers, director generals, directors, 
regional health bureau heads and deputy heads. As 
described in the Ethiopian health sector governance 
framework in the Health Sector Transformation Plan 
(HSTP), these groups are responsible for decision- 
making in the health sector, both technically and at 
the policy level.18 Therefore, they discussed and 
defined the scope and goal of the revised EHSP, the 
selection criteria, the proposed payment mechanism, 
the level of health care delivery and the budget impact 
of the package. The final, prioritized list of interven-
tions was approved by the same group.19
Two rounds of dialogue were conducted with 
external stakeholders, including public representa-
tives, professional unions and disease-specific 
patient organizations. The first meeting discussed 
the prioritization criteria and the second discussed 
the selection of interventions, the proposed pay-
ment mechanism, the service delivery platforms 
and the final validation of the prioritized EHSP. 
Consultation directly with the public at the grass-
roots level remained limited, however.
Use of Multi-criteria Decision-making
Cost effectiveness has long been the most commonly 
applied prioritization criterion in defining health 
benefits package decision-making processes in many 
countries.38,39 Recently, multi-criteria decision- 
making (MCDM) has become a widely accepted 
approach because UHC is not merely about maximiz-
ing health.40 FRP, equity impact and budget impact 
are also important and must be considered. Public 
and political acceptability is likewise, important con-
siderations. In this regard, the Ethiopian EHSP was 
revised through an MCDM process.19
Linking with Service Delivery and Financing 
Mechanisms
A well-designed EHSP should inform policy 
makers on how to better organize the health sys-
tem in terms of payment mechanisms, delivery 
platforms, specific implementation plans and 
monitoring and evaluation methods.18,24 In this 
regard, the interventions in the EHSP are aligned 
with clearly defined levels in the current service 
delivery platform. Because translating the inter-
vention lists into real-world service provision 
requires linking with financing arrangements, the 
Table 2. Interventions by major program area and sub-program 
area
Major program areas and sub-program areas N %
RMNCH 333 32.7
Nutrition 130 12.8
Child health 88 8.6
Sexual and reproductive health 60 5.9
New-born health 34 3.3
Maternal health services 21 2.1
NCD 218 21.4
Cancer 68 6.7
Cardiovascular disease 28 2.8
Diabetes mellitus 6 0.6
MNSUD*: Childhood mental disorders 11 1.1
MNSUD: Substance use disorders 14 1.4
MNSUD: All 4 0.4
MNSUD: Mental disorders 20 2.0
MNSUD: Neurological disorders 4 0.4
NCDs: All 33 3.2
Non-communicable eye health problems 8 0.8
Renal diseases 8 0.8
Respiratory diseases 14 1.4
Surgical and injury care 181 17.8
Anesthesia 16 1.6
Surgical care 165 16.2
Multisectoral nutrition interventions 64 6.3
Multisectoral nutrition interventions 64 6.3




Sexually transmitted infections 11 1.1
Leprosy 4 0.4
Health education and BCC 57 5.6
Health education and promotion 57 5.6
Emergency and critical care 39 3.8
Emergency and critical care: All 5 0.5
Pre-hospital emergency care 8 0.8
Basic emergency care 2 0.2
Advanced emergency care 24 2.4
NTDs 35 3.4
NTDs 35 3.4
Hygiene and environmental health services 29 2.8
Hygiene and environmental health 29 2.8
Grand Total 1,018 100.0
* MNSUD = Mental Neurological and Substance Use Disorder. 
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revised EHSP also provides possible ways to 
finance the package. The costs of the interventions 
were estimated to determine the budget impact, 
and the expected available resources in the next 
10 years were estimated using basis-case, low-case 
and high-case scenarios.19
Experiences of Other Countries
The process of revising the Ethiopian EHSP shared 
many similarities with other African, Asian and 
Latin American counties’ experiences in terms of 
using evidence and multiple criteria, involving 
a wide range of stakeholders and maximizing 
public participation in decision-making.9,41-43 For 
instance, multiple criteria such as disease burden 
information, effectiveness, cost-effectiveness analy-
sis, equity impact, FRP and the budget impact was 
employed in benefit package revisions in Mexico, 
Chile, Thailand, the Philippines and Ghana.44-49 In 
Malawi and Zimbabwe, however, only cost effec-
tiveness and disease burden information was used 
to set priorities.50,51
Regarding public participation and stakeholder 
engagement, evidence from both high-income and 
low-income settings indicates that engaging all 
stakeholders from the initial stage of the revision 
process through the final stage is not only vital to 
Figure 3. EHSP interventions by major program area and level of priority
Figure 4. EHSP interventions by major program area and delivery platform
* Primary care includes community-based interventions, health posts, health centers and primary hospitals. 
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increasing the acceptability of the final health ser-
vice package but also helpful in addressing the 
concerns of various groups.52 As in the Ethiopian 
case, the revision process in Chile, Thailand and 
Malawi was participatory.44,51,53 However, in the 
Ethiopian revision process, the public participation 
did not involve the direct participation of the 
citizenry. In the next round of revision of the 
EHSP, we recommend that town hall meetings be 
conducted to elicit public opinion directly.
The main difference between the Ethiopian 
EHSP and those of many other countries is the 
comprehensive scope of the interventions in the 
package. In the Ethiopian EHSP, 1,018 interven-
tions, ranging from multisectoral population-level 
policy interventions (e.g., enforcing the taxation of 
alcohol, cigarettes, khat and sugary beverages) to 
specific and specialized clinical services (e.g., pal-
liative care for colorectal cancer) were included. 
Unlike in the Ethiopian case, the benefits package 
in some other countries was neither comprehen-
sive nor explicit. For example, the Mexican EHSP 
began with 90 interventions48 and expanded over 
time to 297, and Zimbabwe’s EHSP has only 65 
interventions.50 In Malawi, 67 interventions are 
included.51 Having an explicit, comprehensive 
health service package is an opportunity to ensure 
the inclusion of important interventions from all 
program areas in the benefits package.12,35 This is 
especially important in settings such as Ethiopia, 
where the institutional and technical capacity to 
continuously update the package is limited.
Limitations
We believe that lessons learned from the revision 
of the Ethiopian EHSP can be useful to other low- 
income countries. The revision aimed to be an 
extensive, participatory, inclusive, evidence-based, 
democratic and transparent decision-making pro-
cess. There were, however, limitations related to 
data sources and analytic approaches that merit 
consideration when applying the findings of this 
study in other settings.
The first limitation was that the Delphi techni-
que was applied to systematically generate equity 
and FRP scores based on expert opinion because 
of the limited available data on the equity and FRP 
impacts of the interventions. This approach is 
a good way to synthesize expert opinion when 
other data are not available. Although the applica-
tion of the Delphi technique provided the oppor-
tunity to explore the equity impact and FRP from 
a wider perspective (i.e., including socioeco-
nomics, geography, gender, age, etc.), it is less 
precise and prone to various types of biases. 
Therefore, more studies on equity impact analysis 
and more FRP studies should be conducted. Had 
more extended cost-effectiveness analyses been 
conducted, we would have had more relevant evi-
dence available. Furthermore, methods develop-
ment could advance the application of the Delphi 
method and other nominal group techniques in 
a way that could provide a better estimate of the 
equity and FRP impact of interventions.
Figure 5. EHSP interventions by major program area and payment mechanism
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A second limitation was the lack of contextualized 
cost-effectiveness analyses. Although we extracted 
cost-effectiveness information for a large majority 
of the interventions from peer-reviewed articles of 
good quality and from a comprehensive systematic 
review provided by DCP3 and others, the transfer-
ability and standardization of the results remain 
imperfect because of factors including inconsistent 
designs (discounting, perspective, currency, etc.) and 
inconsistent and nontransparent reporting. In addi-
tion, demographic, epidemiologic, and health system 
variation across setting where the original studies 
were conducted has made transferability of cost- 
effectiveness ratios more challenging.
A third limitation concerns our general approach 
to benefit package design. There are three approaches 
to defining an EHSP: positive listing, negative listing 
and a mix of the two approaches. We applied 
a positive listing approach. A mixed approach 
might have been better in a situation in which there 
were significant data limitations on the cost and 
impact of several interventions. High-cost interven-
tions with modest health impacts (e.g., new immu-
notherapies for cancer) can be listed in the negative 
list based on evidence from high-income countries. 
This could have informed decision makers about 
what not to invest in.53 Because health needs, disease 
patterns and health care technology change quickly 
over time, however, the MoH has a plan to institu-
tionalize a continuing health technology assessment 
(HTA) mechanism for assessment and appraisal of 
new technologies and update the list of interventions 
on an ongoing basis. In addition, the Ethiopian gov-
ernment should revise the EHSP regularly every 
five year.
Lack of expertise in health economics and HTAs 
in the country can be another limitation, but the 
long-term investment in the Disease Control 
Priorities–Ethiopia project has largely circumvented 
that limitation in this setting. Therefore, continuous 
capacity building and the training of health econo-
mists are crucial to strengthening the use of evi-
dence in strategic purchasing for UHC in Ethiopia 
and other low- and middle-income countries.54
Conclusion
The revision of Ethiopia’s EHSP used a participatory, 
inclusive, evidence-based prioritization process. The 
interventions included in the EHSP were compre-
hensive, assigned to health care delivery platforms 
and linked to financing mechanisms.
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